WO2004091528A2 - Delivery systems of homogeneous thermoreversible alginate films - Google Patents

Delivery systems of homogeneous thermoreversible alginate films Download PDF

Info

Publication number
WO2004091528A2
WO2004091528A2 PCT/US2004/011600 US2004011600W WO2004091528A2 WO 2004091528 A2 WO2004091528 A2 WO 2004091528A2 US 2004011600 W US2004011600 W US 2004011600W WO 2004091528 A2 WO2004091528 A2 WO 2004091528A2
Authority
WO
WIPO (PCT)
Prior art keywords
film
delivery system
alginate
agent
gel
Prior art date
Application number
PCT/US2004/011600
Other languages
French (fr)
Other versions
WO2004091528A3 (en
WO2004091528B1 (en
Inventor
Arthur D. Ballard
Christopher J. Sewall
James J. Modliszewski
William R. Blakemore
Peter J. Riley
Original Assignee
Fmc Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corporation filed Critical Fmc Corporation
Priority to JP2006510060A priority Critical patent/JP2007525451A/en
Priority to BRPI0409336-4A priority patent/BRPI0409336A/en
Priority to EP04759551A priority patent/EP1622588A2/en
Publication of WO2004091528A2 publication Critical patent/WO2004091528A2/en
Publication of WO2004091528A3 publication Critical patent/WO2004091528A3/en
Publication of WO2004091528B1 publication Critical patent/WO2004091528B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/737Galactomannans, e.g. guar; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Definitions

  • the present invention is directed to a delivery system comprising a homogenous, thermoreversible gel film, wherein the gel film comprises: (i) a film forming amount of water soluble theraioreversible alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent; and (ii) an active substance.
  • the present invention is also directed to a process for the manufacture thereof.
  • the present invention generally relates to delivery systems comprising a gel film that can be used to contain and deliver a wide variety of active substances.
  • WO 02/43657 discloses the use of pullulan free edible film compositions containing at least one film forming agent, at least one bulk filler agent, at least one plasticizer. These films can contain a number of materials such as medicaments and can be used for a number of applications in oral care; e.g., breath freshening strips.
  • the film forming agent is widely described as being any of cellulose ethers (stated to include: methylcellulose, ethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose; carboxymethylcellulose and derivatives thereof); modified starches (stated to include acid and enzyme hydrolyzed corn and potato starches); natural gums (stated to include gum Arabic, guar gum, locust bean gum, carrageenan gum, acacia, karaya, ghatti, tragacanth agar, tamrind gum, xanthan gum and derivatives thereof); edible polymers (stated to include microcrystalline cellulose, cellulose ethers, xanthan and derivatives thereof); hydrocoUoid flours (stated to include guar gum, locust bean, microcrystalline cellulose, tara and derivatives thereof); seaweed extracts (stated to include alginate, carrageenan and derivatives thereof); and land plant extract (stated to include konjac, pect
  • WO 00/18365 discloses fast dissolving orally consumable films used to deliver breath deodorizing agents, antimicrobial agents and salivary stimulants to the oral cavity.
  • the film forming agent to be used in making the film of the invention is said to be selected from pullulan, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, xanthan gum, tragacanth gum, guar gum, acacia gum, Arabic gum, polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, casein and mixtures thereof.
  • the present invention is directed to a delivery system comprising a homogenous, thermoreversible gel film, wherein said gel film comprises: (i) a film forming amount of a water soluble thermoreversible alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent; and (ii) an active substance.
  • the present invention is directed to a process for preparing the homogeneous gel film delivery system described immediately above comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de- aerating the alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; (ii) adding an effective amount of an active substance either prior to or after formation of the molten composition; and (iii) cooling the molten composition containing the active substance at or below its gelling temperature to form the gel films containing the active substance.
  • Figure 1 is a partially broken away, side elevational view of the fluid mixing apparatus for mixing first and second fluids with steam that can be used in the process of the present invention.
  • Alginates derived from, ter alia, brown seaweeds ⁇ Phaeophyceae sp.
  • Alginates are linear unbranched chemical polymers containing (l-4)-linked ⁇ -D-mannuronic acid (M) and ⁇ - L-guluronic acid (G) residues.
  • Alginates are not random copolymers, but consist of blocks of similar and alternating residues, for example, MMMM; GGGG, and GMGM, and are generally useful in the form of alginic acid or salts thereof.
  • Alginates that are useful in the present invention include the monovalent salts of alginate such as sodium and potassium alginate, as well as the esterif ⁇ ed forms of alginate such as propylene glycol alginate. All such esterified forms are encompassed within the definition of alginates as used herein. Additional examples of alginates useable in the present invention include magnesium alginate and 3-ethanol amine alginate. Such alginates may be used solely or in combination with other alginates of the present invention, and such other alginates may include small amounts of other cations provided such do not, as discussed in more detail below, adversely impact the gel formation or homogeneity of the gel film. The alginates may be fully, partially or not clarified from the raw material.
  • Certain alginates e.g., sodium alginate
  • alginates are generally considered to produce thermally irreversible gels with calcium ions.
  • such alginates in accordance with the present invention, have been found to produce homogeneous, thermoreversible gel films having significant film strength.
  • certain alginates such as propylene glycol alginate, are generally considered to be non-gelling.
  • propylene glycol alginate has been shown to provide a homogenous, thermoreversible gel film having significant film strength.
  • Alginate is known to react and crosslink with available polyvalent cations (ionic) such as calcium. This crosslinking can adversely impact the film formation and thermoreversibility of the alginate gel films depending on the polyvalent cation used; e.g., magnesium does not adversely impact the thermoreversibility of the alginate gel film. Therefore, it is important that the alginate have levels of those polyvalent cations that adversely impact the film formation and thermoreversibility of the alginate film below the point that such impair film formation or thermoreversibility within the alginate system.
  • polyvalent cations ionic
  • Such polyvalent cation (e.g., calcium) levels are generally used in an amount of no higher than 5.0%, more preferably, less than 2.0%, more preferably, less than 1.0% by weight based on the dry weight of the alginate in the gel film, but this can vary depending on the effect of other components, alginate type and source, and the use of sequestering agents, etc. Sequestering or chelating agents could be added in sufficient amounts to minimize the above adverse polyvalent cation solubility (and participating activity) of e.g., calcium.
  • the alginate is used in the present invention in a film forming amount (e.g., an amount that adds strength to the gel film) which is distinguished from trace amounts of alginate that do not add film properties to the film.
  • a film forming amount of alginate is an amount that adds film strength to the overall film.
  • Such film forming amounts are generally at least 0.25% by weight of the dry gel film, particularly, 0.5% to 90%, more particularly, 0.5% to 50%, more particularly, 0.25 to 25% by weight of the dry gel film depending on the application.
  • the gel films of the present invention are homogeneous, thermoreversible films.
  • homogeneous film defines films that, to the naked eye, are visually uniform and free of defects such as lumps, cracks, particles that are undissolved that should be dissolved, non-uniform distribution of insoluble particles, etc. "Fish eyes” (mixed liquid and solid states) or “gel balls” (non-uniform gel structure) would not meet the definition of "homogeneous” as used herein.
  • the gel films of the present invention are homogeneous, thermoreversible gel films.
  • thermosible film defines a film that has a melting temperature.
  • melting temperature is the temperature or temperature range over which the film softens or flows.
  • gel films refer to thin membranes formed of structured alginate.
  • the gel forming composition is characterized by a gel temperature, the temperature below which the molten mass must be cooled to form a self supporting structure.
  • a molten mass can be cast hot and allowed to cool, as well as dry to further concentrate the solids (controlled moisture removal) until a gel film is formed by the gel composition.
  • the melt temperature of a thermoreversible gel film is higher than its gel temperature.
  • the gel film of the present invention includes an active substance.
  • Examples of active substances that may be contained within the gel film is at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, a vitamin, a mineral, a coloring agent, cosmetic ingredient, agricultural active, a sweetener, a flavorant, a fragrance or a food.
  • the homogeneous, thermoreversible gel film of the present invention can optionally contain at least one of a plasticizer, a second film former, a bulking agent and a pH controlling agent.
  • a plasticizer e.g., ethylene glycol dimethacrylate copolymer, polymethyl methacrylate copolymer, polymethyl methacrylate copolymer, polymethyl methacrylate copolymer, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, polymethyl methacrylate, poly
  • plasticizer examples include polyols such as glycerin, sorbitol, maltitol, lactitol, corn starch, polydextrose, fructose, solubilized oils, and polyalkylene glycols such as polyethylene glycol and propylene glycol.
  • plasticizers should generally be used in an amount of at least 5%, more preferably, at least 10%, more preferably, at least 20%, more preferably, at least 30% by weight of all the components including water in the dry film depending on the desired elasticity of the delivery system. It is possible that the delivery system contains no plasticizer at all.
  • Examples of the second film former that can be used in the present invention include at least one of a starch, starch hydrozylate, starch derivative, cellulose gum, hydrocoUoid, an alkylcellulose ether or a modified alkyl cellulose ether.
  • Examples of the hydrocoUoid include at least one of kappa carrageenan, kappa-2 carrageenan, iota carrageenan, polymannan gums such as locust bean gum or guar gums including low viscosity guar gum, dextrans, pullulan, gellan (including high and low-acyl gellan), pectin and less than fully modified versions thereof and combinations thereof.
  • kappa-2 carrageenan has a molar ratio of 3:6-anhydrogalactose-2-sulfate (3:6AG- 2S) to 3:6-anydroglactose (3:6AG) content of 25 to 50%
  • iota carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content of 80 to 100%
  • kappa carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content less than that for kappa-2 carrageenan.
  • kappa carrageenan from Eucheuma cottonii a commonly known and used seaweed source for kappa carrageenan
  • iota carrageenan from Eucheuma Spinosum a commonly known and used seaweed source for iota carrageenan
  • Kappa-2 carrageenan can be obtained from, for example, from Gigartina skottsbergii. Kappa, kappa-2, and iota carrageenans are different from each other in both structure and functionality.
  • such carrageenan can have a viscosity of 19 cps or less, more particularly less than 10 cps, at 75 °C in a 0.10 molar sodium chloride solution containing 1.5% of the reduced molecular weight carrageenan based on the total weight of the solution.
  • This viscosity test can be performed using a Brookfield LVF (Brookfield Engineering Laboratories, Inc.) viscometer using Spindle #1 at 60 r.p.m. and deteraiining the viscosity after six revolutions.
  • an alkylcellulose ether that can be used in the present invention is hydroxyethylcellulose.
  • modified alkylcellulose ethers that can be used in the present invention include hydroxypropylcellulose and hydroxypropylmethyl-cellulose.
  • some second film formers such as carrageenan, can contain cations that can have positive and negative impacts on gelling properties and film strength with the carrageenan and/or the alginate.
  • beneficial cations include postassium, magnesium and ammonium. These cations can be present in the carrageenan or added to it from other organic or inorganic sources. These beneficial cations can be present in an amount of less than 20% by dry weight of the alginate in the gel film (including water). This amount can be varied depending on the components in the system and desired melt and sealing temperatures.
  • cations such as calcium (as mentioned above), aluminum and chromium can adversely crosslink with alginate and/or impact carrageenan stability and should be kept to a minimum, such as less than 5%, less than 2%, less than 1% by dry weight of the alginate in the dry gel film (including water).
  • the alginate can be the only film former in the gel film.
  • the alginate can be present in an amount of at least 10%, at least 40%, at least 60% or at least 80% by weight of the total amount of film formers in the dry gel film.
  • modified starches includes such starches as hydroxypropylated starches, acid thinned starches and the like.
  • modified starches that can be used in the present invention include Pure CoteTM B760, B790, B793, B795, M250 and Ml 80, Pure-DentTM B890 and Pure- SetTM B965, all available from Grain Processing Corporation of Muscatine, Iowa, and C AraTexTM 75701, available from Cerestar, Inc.
  • modified starches are products prepared by the treatment of starches, for example, acid treatment starches, enzyme treated starches, oxidized starches, cross-bonding starches and other starch derivatives. It is preferred that the modified starches be derivatized wherein side chains are modified with hydrophilic or hydrophobic groups to thereby form a more complicated structure with a strong interaction between side chains.
  • the amount of the bulking agent to be used in the present invention is generally 0 to 20% by weight of the dry film, but more can be used, if desired, for example, at least 20%, more preferably, at least 30% by weight of the dry film depending on the use of the delivery system.
  • starch, starch derivatives and starch hydrozylates can be multifunctional. That is, in addition to being used as bulking agents, they can be used as second film formers. When such are used as bulking agents and second film formers, they are generally used in an amount of at least 10%, preferably, at least 20%, by weight of the dry gel film.
  • Examples of the pH controlling agent to be used in the present invention include bases such as hydroxides, carbonates, citrates and phosphates.
  • the pH controlling agent can be used to improve the stability of the gel film.
  • the pH controlling agent can be chosen as the source of added beneficial cations such as potassium or ammonium.
  • the amount of the pH controlling agent is generally in the amount of 0 to 4%, more preferably, 0 to 2% by weight of the dry film.
  • the dry films (e.g., 80% solids or higher) made from the gels of the present invention have been found to have, for example, a break force strength of at least 250 grams, at least 1,000 grams, at least 2,500 grams, at least 4,000 grams, at least 5,000 grams, and at least 6,000 grams, as determined using a Texture Analyzer TA 108S Mini Film Test Rig. Furthermore, dry films of the invention have been shown to have a break force strength in excess of 7,000 and 8,000 grams.
  • the gel films of the present invention have been found to have a solids content of at least 50%, at least 60%, at least 70%, at least 80% and at least 90% of all components in the gel film. It is understood that up to 15%, 10% or 5% water may remain strongly associated with the solids in the dry gel film.
  • the gel films of the invention can also contain colorants and flavorants such as sugar, corn syrup, fructose, sucrose, etc, whether or not other components, such as plasticizers, bulking agents, second film formers, etc. are present.
  • One embodiment of a gel film of the invention comprises the alginate described herein, flavorant and water in a high solids system; e.g., greater than 50%, 60%, 65%, 75%, 80%, 85%, 90% solids.
  • the gel films of the present invention can contain non- thermoreversible gums.
  • non-thermoreversible gums include (e.g., crosslinked and partially crosslinked) gums such as calcium set (crosslinked) pectins or alginates. Calcium reactive alginates and pectins, as well as their less refined forms, are considered as thermoreversible gums in the absence of divalent cations.
  • the films of the present invention are generally made from a process utilizing an apparatus that enables sufficiently high shear, temperature (above the gelling temperature) and residence time so as to provide a homogeneous molten mass of the composition and allow formation of the gel upon cooling. This is generally accomplished in the apparatus by heating, hydrating, mixing, solubilizing and optionally deaerating the composition.
  • Examples of such an apparatus include Ross mixers, Stephan processors, extruders, jet cookers and the fluid mixing apparatus as set forth in Figure 1. Ross mixers, Stephan processors and conventional jet cookers are readily available commercially.
  • the molten mass Prior to cooling, the molten mass may optionally be fed to at least one of a pump, mixer or devolatilizer; e.g., s an extruder.
  • the molten mass need not necessarily reach homogeneity in step (i). That is, when an additional apparatus such as a mixer, pump and/or devolatilizer is used, homogeneity of the molten mass can be obtained prior to or after feeding the molten composition into at least one of the mixer, pump and/or devolatilizer provided the molten mass reaches homogeneity prior to gelling.
  • An extruded molten mass can also be directed to a film forming or shaping device (e.g. spreader box) that aids in the uniform casting of a continuous film, or, through a die that allows a direct formation of a film or shaped extrudate from the molten mass delivery equipment.
  • a film forming or shaping device e.g. spreader box
  • homogeneity of the molten mass can be obtained prior to or after feeding the molten composition into at least one of the mixer, pump or devolatilizer provided the molten mass reaches homogeneity prior to gelling.
  • FIG. 1 illustrates a fluid mixing apparatus 10.
  • the fluid mixing apparatus 10 is arranged to mix steam 2 with a first fluid or slurry 4 and a second fluid or slurry 6 to produce a molten mass or slurry mixture 8.
  • the fluid mixing apparatus 10 comprises a first housing 20 having a first inlet 22 through which the steam 2 enters the housing 22, a nozzle end 24 from which the steam 2 exits the housing 20, and a nozzle valve or stem 26 disposed at the nozzle end 24.
  • An actuator means 30 is connected to the first housing 20 for controlling the exit rate or exit pressure of the first fluid 2 at the nozzle end 24.
  • the actuator means 30 may be of the type manufactured by Fisher Controls U.S.A.
  • the fluid mixing apparatus 10 further comprises a second, mixing housing 40 coupled to the first housing 20 at the nozzle end 24 of the first housing 20.
  • the second housing 40 includes a second inlet 42 through which the first fluid 4 enters the second housing 40, and a third inlet 44 through which the second fluid 6 enters the second housing 40.
  • the inlets 42 and 44 are disposed downstream of the first inlet 22. As shown in FIG. 3, the second inlet 42 and third inlet 44 are disposed in a common plane and spaced apart radially from each other, most preferably directly opposite (i.e., 180° apart) about the central axis Y of the mixing apparatus 10.
  • the second housing 40 defines a generally cylindrical mixing chamber 52 that in turn defines a flow passage extending along the axial length of the mixing chamber 52 from an entry end 54 of the mixing chamber 52 to an exit end 56 of the chamber 52.
  • the nozzle valve 26 is movable by the actuator 30 between seated and unseated positions at the entry end 54 to control the flow rate of steam 2 into the mixing chamber 52.
  • the nozzle end 24 of the first housing 20 directs the steam 2 into the entry end 54 of the mixing chamber 52.
  • the second inlet 42 and the third inlet 44 radially direct the first fluid 4 and second fluid 6, respectively, into the mixing chamber 52.
  • the steam 2, first fluid 4 and second fluid 6 are mixed in the mixing chamber 52 to form a molten mass or mixture 8 which exits the mixing chamber 52.
  • the molten mass 8 then may be shaped into a shaped article or formed into a film, such as by casting the mixture 8 onto a cooling drum or by passing the mixture 8 through an extruder.
  • the fluid mixing apparatus 10 is adapted to produce a mixture for forming a film, more particularly an edible film for making edible delivery systems.
  • Incompatible film components generally are placed in different fluid inlet streams so that such incompatible components come together in the first instance at the interface of the steam injection within the mixing chamber 52 of the fluid mixing apparatus. While FIG. 1 shows inlets for steam, and first and second fluids, one or more additional inlets for one or more additional fluids may be provided.
  • the housings 20, 40 and other components of the fluid mixing apparatus 10 are constructed of high-grade stainless steel.
  • the gel film can also be used to modify the dissolution profile of the dosage forms.
  • gel films of the invention can contain added components that can create solid dosage forms having immediate release, enteric or delayed release capabilities. Definitions of "immediate release”, “delayed release” and “enteric” can be found in the U.S. Pharmacopeia and are incorporated herein by reference.
  • the Stephan UMC5 processor is a laboratory scale mixing device that provided suitable high shear mixing, heating, and deaerating of the formulations which were cast as films in the laboratory.
  • a suitable batch size used was 1500 grams.
  • aqueous starch dispersion was prepared by dissolving any salts/buffers and pH modifiers in deionized water. The starch and/or maltodextrin (Ml 00) were added and mixed until dissolved/dispersed. Pure Cote® B760 starch is available from the Grain Processing Coiporation of Muscatine, Iowa. A hydrocoUoid mixture was prepared in the Stephan UMC5 processor by premixing the plasticizers until uniform, and adding the preblended dry hydrocoUoids portionwise while mixing for about 30 seconds at 200 rpm after each addition. Sorbitol Special and glycerin were used as plasticizers. Sorbitol Special is an aqueous solution of sorbitol and sorbitol anhydrides at 76% solids supplied by SPI Polyols, Inc. (New Castle, DE).
  • the starch dispersion was added to the non-aqueous hydrocoUoid mixture and mixed at 300 rpm for 5 minutes.
  • the mechanical agitation was increased to 2100 rpm and the mixture was heated to 85°C to 95°C with mixing.
  • the target temperature was achieved, the mixture was stirred for 30 minutes, then the sample was held under vacuum (50-60 bars) with continued agitation for an addition 45 minutes.
  • a small portion of the sample was set aside and refrigerated usually overnight prior to measurement of gel/melt properties and solids using an Atago E series hand held refractometer (Gardco, Pompano Beach, FL).
  • the melt temperature was determined by placing a small chunk of the refrigerated gel on a wire string stand held within a test tube so that the chunk does not contact the wall of the test tube.
  • the test tube was covered with aluminum foil with a small hole to allow measurement of the gel temperature using a digital tempermeter probe. The test tube was immersed in the heating bath so that the
  • test tube was
  • the temperature probe was used to record the temperature as the sample was cooled and to probe the sample surface to determine whether the sample had begun to gel.
  • the gel temperature was the temperature upon cooling where the sample no longer flowed to fill in an indentation made by the probe.
  • the hot sample was then cast, using a draw down bar with a gap set at 3 mm clearance, onto 177 mm by 177 mm by 5 mm metal plates which were pre-sprayed with PAM (lecithin) to facilitate easy removal of film material.
  • the gel coated plates were covered to avoid loss of moisture on the cast film and refrigerated (less than 8°C) for at least one-half hour prior to removal of the film for testing. Refrigeration is not required for film formation.
  • Dried film strips were prepared by drying the coated plates in a 40°C forced air/fan oven. Films dried 2 hours at 40°C gave an intermediate solids of about 60% while films dried overnight at 40°C typically gave solids of 80% or higher. Test properties were measured at room temperature (about 20°C) unless otherwise indicated. The percent of solids in the dried film was determined by difference in weight between the cast film using its formulated solids and the dried film. Break force strengths were measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test
  • Table I lists compositions and properties of gel films prepared using blends of sodium alginates with low viscosity guar Edicol ULN 50 obtained commercially from Indian Gum Industries Ltd..
  • Protanal® LFR 5/60, Protanal® LF 20/40 and Protanal® SF 120 RB are sodium alginates available from FMC Corporation (Philadelphia, PA).
  • Example 1-1, 1-2 and 1-3 Temperature and viscosity of molten mass prior to casting Increasing the molecular weight of the sodium alginate contributed to the overall film structure and resulted in increased film strength (Examples 1-1, 1-2 and 1-3).
  • the melt temperatures above were measured by heating the gel films using an oil bath. When heated, they soften and could be stirred. When allowed to cool, the gel formed above room temperature.
  • KAHG was the potassium salt of alginic acid extracted from Laminaria hyperborean and contains a high level guluronic acid (G) units.
  • KAHM was a potassium salt of alginic acid extracted from Lessonia nigrescens and has a high level of mannuronic (M) units.
  • the viscosity of the KAHG and KAHM were 5 cps and 12 cps, respectively, when measured in a 1% solution of water at 25°C.
  • Potassium cation associated with the alginate is beneficial for the initiation of the structuring of kappa carrageenan and/or kappa-2 carrageenan with the alginate into a homogeneous cast & set film.
  • the kappa carrageenan was an alkali processed, clarified extract of Kappaphycus alaverei ⁇ Eucheuma cottonii). All hydrocoUoids used had low levels of divalent cations as shown in Table II.
  • Table III presents compositions and properties of films formed using mixtures of potassium alginates and other film formers such as kappa carrageenan and low viscosity guar gum available as Edicol ULV 50 from Indian Gum Industries.
  • Table III FUms Using Low Viscosity Guar, Potassium Alginates and Carrageenan
  • Temperature and viscosity of the molten mass prior to casting Results indicate beneficial interaction by combining potassium alginate, either high guluronic or high mannuronic, or combinations thereof, with kappa carrageenan and guar. Further variation of weight ratios of alginate and second film formers and process variations can also be used to, again, either cast as a high solids (>80%) molten mass, formed, and cooled gel film as is or for further processing.
  • Table IN lists compositions and properties of gel films prepared using propylene glycol alginate and kappa carrageenan.
  • Protanal® ester BN4830 is a propylene glycol alginates available from FMC Corporation (Philadelphia, PA).
  • HEC is hydroxyethylcellulose.
  • Kappa carrageenan is described above in Example 2.
  • Table V reports compositions and film properties for kappa-2 carrageenan used in combination with propylene glycol alginate and potassium alginate.
  • the kappa-2 carrageenan was an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata, primarily haploid (gametophyte) plants.
  • potassium cations are supplied by the potassium alginate.
  • the potassium cations promote carrageenan double helix formation at a temperature that allows the carrageenan to form its gel film structure.
  • the additional strength and lower processing viscosity is due to the higher level of propylene glycol alginate.
  • Table VI presents compositions and gel films formed from low viscosity guar Edicol ULV 50 in combination with propylene glycol alginate and other hydrocoUoids.
  • Protanal® ester BV4830 and Protanal® ester SLF3 are propylene glycol alginates available from FMC Corporation (Philadelphia, PA) and Kibun, respectively.
  • the SLF-3 has a lower molecular weight compared to the BV-4830.
  • HEC is hydroethylcellulose.
  • Glycerin 83 83.0 83.0 88.2
  • Part A and Part B were pumped from separate holding tanks at ambient temperature, as two separate streams 4, 6, into two different inlet ports 42, 44 which fed the steam injection fluid mixing apparatus device 10.
  • the two individual streams 4, 6 were combined at the interface of the steam in the mixing zone 52 of the fluid mixing apparatus 10.
  • the separate solutions of Part A and Part B were readily pumped into the fluid mixing apparatus 10 and mixed with steam 2.
  • the steam 2 was introduced to the mixing zone at a pressure of 120 psi.
  • the resulting molten mass or slurry mixture 8 flowed out of the exit port 56 of the fluid mixing apparatus 10.
  • the mixture 8 was poured onto a smooth surface and drawn down to form a homogeneous film 9.
  • the molten mass 8 was collected from the outlet 56 then cast using a draw down bar, with a gap set at 3 mm, onto a stainless steel metal plate.
  • the initial films 9 or "fresh films” were collected. Portions of the fresh films 9 were dried by placing them in a 40°C forced air oven. Break force was measured on the fresh and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig. The percent solids were determined by measuring the difference between the initial weight of the fresh film and the final weight of the dried films.
  • thermometer was inserted into the molten mass 8. The material 8 was allowed to cool under room temperature conditions. After each degree of cooling, the thermometer was removed from the material 8. When a small, temporary indentation was observed in the surface of the mass 8, this temperature was recorded. The thermometer was re-inserted into the mass 8, which was allowed to cool further. The thermometer was removed and re-inserted at every degree of cooling until such a time as a permanent indentation formed in the mass 8, such that the indentation did not refill. The temperature at which the permanent indentation formed was recorded. The gel temperature reported was the range between the two recorded temperatures.
  • Table VII shows that the film former can be a combination of hydrocoUoids, such as carrageenan and PGA. Additionally, salts can be added to influence film properties such as strength, gel temperature and pH.
  • Delivery films of the invention were prepared by the following method: alginate and kappa carrageenan were dry blended to form a gum blend.
  • KAHG and NAHG were the potassium salt and the sodium salt, respectively, of alginic acid extracted from Laminaria hyperborean and contains a high level guluronic acid (G) units.
  • KAHM was a potassium salt of alginic acid extracted from Lessonia nigrescens and has a high level of mannuronic (M) units.
  • the 1% aqueous solutions of the KAHG and KAHM had a viscosity of 5 cP and 12 cP, respectively, when measured in a 1% solution of water at 25°C.
  • Maltrin M 100 maltodextrin (Grain Processing Corp., Muscatine, Iowa) was dry blended with the gum blend.
  • Deionized water and glycerin were weighed into a 1.2 liter stainless steel beaker.
  • the dry premix was added to the water with good agitation, then heated to 90 °C and held within the temperature range 90°C to 95°C for 15 minutes to fully hydrate the gums.
  • the delivery ingredient was added and mixed two minutes for dispersion.
  • the delivery ingredients tested were: (1) natural and artificial strawberry flavor (Dragoco, 0.1%), (2) titanium dioxide, and (3) caffeine. The hot solution was quickly poured into containers.
  • Solution cast in petri dishes was cooled to room temperature to form films, then dried overnight in a forced draft oven at 45 °C to a constant weight.
  • a sample was cooled then refrigerated (less than 8°C) overnight prior to measurement of gel/melt properties and solids using an Atago E series hand held refractometer (Gardco, Pompano Beach, FL).
  • the melt temperature was determined by placing a small chunk of the refrigerated gel on a wire string stand held within a test tube so that the chunk did not contact the wall of the test tube.
  • the test tube was covered with aluminum foil with a small hole to allow measurement of the gel temperature using a digital tempermeter probe.
  • the test tube was immersed in the heating bath so that the chunk is below the surface of a hot water bath at
  • test tube was transferred to a second beaker containing
  • the temperature probe was used to record the temperature as the sample was cooled and to probe the sample surface to determine whether the sample had begun to gel.
  • the gel temperature was the temperature upon cooling where the sample no longer flowed to fill in an indentation made by the probe.
  • Break force (BF) and penetration were measured on the cast and dried film strips using a Texture Analyzer TA- 108S Mini Film Test Rig. Rigidity was calculated as the BreakForce divided by the penetration.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Seasonings (AREA)

Abstract

The present invention is directed to a delivery system comprising a homogenous, thermoreversible gel film, wherein the gel film comprises: (i) a film forming amount of water soluble thermoreversible alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent; and (ii) an active substance. The present invention is also directed to a process for the manufacture thereof.

Description

DELIVERY SYSTEMS OF HOMOGENEOUS THERMOREVERSIBLE ALGINATE FILMS
RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application No. 60/462,793, filed on April 14, 2003.
FIELD OF THE INVENTION
The present invention is directed to a delivery system comprising a homogenous, thermoreversible gel film, wherein the gel film comprises: (i) a film forming amount of water soluble theraioreversible alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent; and (ii) an active substance. The present invention is also directed to a process for the manufacture thereof.
BACKGROUND OF THE INVENTION
Use of delivery systems, for example, for oral care actives in breath and cleansing strips, has increased over recent years. The present invention generally relates to delivery systems comprising a gel film that can be used to contain and deliver a wide variety of active substances.
For example, WO 02/43657 discloses the use of pullulan free edible film compositions containing at least one film forming agent, at least one bulk filler agent, at least one plasticizer. These films can contain a number of materials such as medicaments and can be used for a number of applications in oral care; e.g., breath freshening strips. The film forming agent is widely described as being any of cellulose ethers (stated to include: methylcellulose, ethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose; carboxymethylcellulose and derivatives thereof); modified starches (stated to include acid and enzyme hydrolyzed corn and potato starches); natural gums (stated to include gum Arabic, guar gum, locust bean gum, carrageenan gum, acacia, karaya, ghatti, tragacanth agar, tamrind gum, xanthan gum and derivatives thereof); edible polymers (stated to include microcrystalline cellulose, cellulose ethers, xanthan and derivatives thereof); hydrocoUoid flours (stated to include guar gum, locust bean, microcrystalline cellulose, tara and derivatives thereof); seaweed extracts (stated to include alginate, carrageenan and derivatives thereof); and land plant extract (stated to include konjac, pectin, arabinoglactan and derivatives thereof).
WO 00/18365 discloses fast dissolving orally consumable films used to deliver breath deodorizing agents, antimicrobial agents and salivary stimulants to the oral cavity. The film forming agent to be used in making the film of the invention is said to be selected from pullulan, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, xanthan gum, tragacanth gum, guar gum, acacia gum, Arabic gum, polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, casein and mixtures thereof. These films are said to overcome the challenge of maintaining the essential oil interaction and relatively high oil content in certain films sold for oral care purposes.
SUMMARY OF THE INVENTION
As a first embodiment, the present invention is directed to a delivery system comprising a homogenous, thermoreversible gel film, wherein said gel film comprises: (i) a film forming amount of a water soluble thermoreversible alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent; and (ii) an active substance.
As a second embodiment, the present invention is directed to a process for preparing the homogeneous gel film delivery system described immediately above comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally, de- aerating the alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein the temperature is at or above the solubilizing temperature of the composition; (ii) adding an effective amount of an active substance either prior to or after formation of the molten composition; and (iii) cooling the molten composition containing the active substance at or below its gelling temperature to form the gel films containing the active substance.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a partially broken away, side elevational view of the fluid mixing apparatus for mixing first and second fluids with steam that can be used in the process of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
Alginates, derived from, ter alia, brown seaweeds {Phaeophyceae sp.) are linear unbranched chemical polymers containing (l-4)-linked β-D-mannuronic acid (M) and α- L-guluronic acid (G) residues. Alginates are not random copolymers, but consist of blocks of similar and alternating residues, for example, MMMM; GGGG, and GMGM, and are generally useful in the form of alginic acid or salts thereof.
Alginates that are useful in the present invention include the monovalent salts of alginate such as sodium and potassium alginate, as well as the esterifϊed forms of alginate such as propylene glycol alginate. All such esterified forms are encompassed within the definition of alginates as used herein. Additional examples of alginates useable in the present invention include magnesium alginate and 3-ethanol amine alginate. Such alginates may be used solely or in combination with other alginates of the present invention, and such other alginates may include small amounts of other cations provided such do not, as discussed in more detail below, adversely impact the gel formation or homogeneity of the gel film. The alginates may be fully, partially or not clarified from the raw material. Certain alginates, e.g., sodium alginate, are generally considered to produce thermally irreversible gels with calcium ions. To the inventors' surprise, such alginates, in accordance with the present invention, have been found to produce homogeneous, thermoreversible gel films having significant film strength. In addition, certain alginates, such as propylene glycol alginate, are generally considered to be non-gelling. Also to the inventors' surprise, propylene glycol alginate has been shown to provide a homogenous, thermoreversible gel film having significant film strength.
Alginate is known to react and crosslink with available polyvalent cations (ionic) such as calcium. This crosslinking can adversely impact the film formation and thermoreversibility of the alginate gel films depending on the polyvalent cation used; e.g., magnesium does not adversely impact the thermoreversibility of the alginate gel film. Therefore, it is important that the alginate have levels of those polyvalent cations that adversely impact the film formation and thermoreversibility of the alginate film below the point that such impair film formation or thermoreversibility within the alginate system. Such polyvalent cation (e.g., calcium) levels are generally used in an amount of no higher than 5.0%, more preferably, less than 2.0%, more preferably, less than 1.0% by weight based on the dry weight of the alginate in the gel film, but this can vary depending on the effect of other components, alginate type and source, and the use of sequestering agents, etc. Sequestering or chelating agents could be added in sufficient amounts to minimize the above adverse polyvalent cation solubility (and participating activity) of e.g., calcium.
The alginate is used in the present invention in a film forming amount (e.g., an amount that adds strength to the gel film) which is distinguished from trace amounts of alginate that do not add film properties to the film. Thus, for example, in a gel film of the present invention, a film forming amount of alginate is an amount that adds film strength to the overall film. Such film forming amounts are generally at least 0.25% by weight of the dry gel film, particularly, 0.5% to 90%, more particularly, 0.5% to 50%, more particularly, 0.25 to 25% by weight of the dry gel film depending on the application.
The gel films of the present invention are homogeneous, thermoreversible films. As used herein, "homogeneous film" defines films that, to the naked eye, are visually uniform and free of defects such as lumps, cracks, particles that are undissolved that should be dissolved, non-uniform distribution of insoluble particles, etc. "Fish eyes" (mixed liquid and solid states) or "gel balls" (non-uniform gel structure) would not meet the definition of "homogeneous" as used herein.
The gel films of the present invention are homogeneous, thermoreversible gel films.
As used herein, "thermoreversible film" defines a film that has a melting temperature. As used herein the melting temperature is the temperature or temperature range over which the film softens or flows.
As used herein, "gel films" refer to thin membranes formed of structured alginate. The gel forming composition is characterized by a gel temperature, the temperature below which the molten mass must be cooled to form a self supporting structure. Optionally, a molten mass can be cast hot and allowed to cool, as well as dry to further concentrate the solids (controlled moisture removal) until a gel film is formed by the gel composition. The melt temperature of a thermoreversible gel film is higher than its gel temperature. The gel film of the present invention includes an active substance. Examples of active substances that may be contained within the gel film is at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, a vitamin, a mineral, a coloring agent, cosmetic ingredient, agricultural active, a sweetener, a flavorant, a fragrance or a food.
The homogeneous, thermoreversible gel film of the present invention can optionally contain at least one of a plasticizer, a second film former, a bulking agent and a pH controlling agent. The components to be added to the gel film and their amounts can vary depending on the desired characteristics of the alginate delivery system.
Examples of such a plasticizer include polyols such as glycerin, sorbitol, maltitol, lactitol, corn starch, polydextrose, fructose, solubilized oils, and polyalkylene glycols such as polyethylene glycol and propylene glycol. Such plasticizers should generally be used in an amount of at least 5%, more preferably, at least 10%, more preferably, at least 20%, more preferably, at least 30% by weight of all the components including water in the dry film depending on the desired elasticity of the delivery system. It is possible that the delivery system contains no plasticizer at all.
Examples of the second film former that can be used in the present invention include at least one of a starch, starch hydrozylate, starch derivative, cellulose gum, hydrocoUoid, an alkylcellulose ether or a modified alkyl cellulose ether. Examples of the hydrocoUoid include at least one of kappa carrageenan, kappa-2 carrageenan, iota carrageenan, polymannan gums such as locust bean gum or guar gums including low viscosity guar gum, dextrans, pullulan, gellan (including high and low-acyl gellan), pectin and less than fully modified versions thereof and combinations thereof. As used herein, kappa-2 carrageenan has a molar ratio of 3:6-anhydrogalactose-2-sulfate (3:6AG- 2S) to 3:6-anydroglactose (3:6AG) content of 25 to 50%, iota carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content of 80 to 100% and kappa carrageenan has a molar ratio of 3:6AG-2S to 3:6AG content less than that for kappa-2 carrageenan. For example, kappa carrageenan from Eucheuma cottonii, a commonly known and used seaweed source for kappa carrageenan, has a molar ratio of 3:6AG2S to 3:6AG content of less than about 10%; and iota carrageenan from Eucheuma Spinosum, a commonly known and used seaweed source for iota carrageenan, has a molar ratio of 3:6AG2S to 3:6AG content greater than about 85%. Kappa-2 carrageenan can be obtained from, for example, from Gigartina skottsbergii. Kappa, kappa-2, and iota carrageenans are different from each other in both structure and functionality. If desired, where iota, kappa or kappa-2 carrageenan is used as the second film former, such carrageenan can have a viscosity of 19 cps or less, more particularly less than 10 cps, at 75 °C in a 0.10 molar sodium chloride solution containing 1.5% of the reduced molecular weight carrageenan based on the total weight of the solution. This viscosity test can be performed using a Brookfield LVF (Brookfield Engineering Laboratories, Inc.) viscometer using Spindle #1 at 60 r.p.m. and deteraiining the viscosity after six revolutions. An example of an alkylcellulose ether that can be used in the present invention is hydroxyethylcellulose. Examples of modified alkylcellulose ethers that can be used in the present invention include hydroxypropylcellulose and hydroxypropylmethyl-cellulose. Note that some second film formers, such as carrageenan, can contain cations that can have positive and negative impacts on gelling properties and film strength with the carrageenan and/or the alginate. Such beneficial cations include postassium, magnesium and ammonium. These cations can be present in the carrageenan or added to it from other organic or inorganic sources. These beneficial cations can be present in an amount of less than 20% by dry weight of the alginate in the gel film (including water). This amount can be varied depending on the components in the system and desired melt and sealing temperatures.
Other cations, such as calcium (as mentioned above), aluminum and chromium can adversely crosslink with alginate and/or impact carrageenan stability and should be kept to a minimum, such as less than 5%, less than 2%, less than 1% by dry weight of the alginate in the dry gel film (including water).
The alginate can be the only film former in the gel film. When the gel films of the present invention contain second film formers, the alginate can be present in an amount of at least 10%, at least 40%, at least 60% or at least 80% by weight of the total amount of film formers in the dry gel film.
Examples of the bulking agent include microcrystalline cellulose, microcrystalline starch, modified and unmodified starch, starch derivatives, inulin, starch hydrozylates, sugar, com syrup and polydextrose. As used herein and in the claims, the term "modified starches" includes such starches as hydroxypropylated starches, acid thinned starches and the like. Examples of modified starches that can be used in the present invention include Pure Cote™ B760, B790, B793, B795, M250 and Ml 80, Pure-Dent™ B890 and Pure- Set™ B965, all available from Grain Processing Corporation of Muscatine, Iowa, and C AraTex™ 75701, available from Cerestar, Inc. Examples of starch hydrozylates include maltodextrin also known as dextrin. Unmodified starches such as potato starch can also contribute to the film strength when combined with the hydrocoUoids within the scope of the invention. In general, modified starches are products prepared by the treatment of starches, for example, acid treatment starches, enzyme treated starches, oxidized starches, cross-bonding starches and other starch derivatives. It is preferred that the modified starches be derivatized wherein side chains are modified with hydrophilic or hydrophobic groups to thereby form a more complicated structure with a strong interaction between side chains.
The amount of the bulking agent to be used in the present invention is generally 0 to 20% by weight of the dry film, but more can be used, if desired, for example, at least 20%, more preferably, at least 30% by weight of the dry film depending on the use of the delivery system.Note that starch, starch derivatives and starch hydrozylates can be multifunctional. That is, in addition to being used as bulking agents, they can be used as second film formers. When such are used as bulking agents and second film formers, they are generally used in an amount of at least 10%, preferably, at least 20%, by weight of the dry gel film.
Examples of the pH controlling agent to be used in the present invention include bases such as hydroxides, carbonates, citrates and phosphates. The pH controlling agent can be used to improve the stability of the gel film. For some compositions containing second film formers, the pH controlling agent can be chosen as the source of added beneficial cations such as potassium or ammonium. The amount of the pH controlling agent is generally in the amount of 0 to 4%, more preferably, 0 to 2% by weight of the dry film.
The dry films (e.g., 80% solids or higher) made from the gels of the present invention have been found to have, for example, a break force strength of at least 250 grams, at least 1,000 grams, at least 2,500 grams, at least 4,000 grams, at least 5,000 grams, and at least 6,000 grams, as determined using a Texture Analyzer TA 108S Mini Film Test Rig. Furthermore, dry films of the invention have been shown to have a break force strength in excess of 7,000 and 8,000 grams.
The gel films of the present invention have been found to have a solids content of at least 50%, at least 60%, at least 70%, at least 80% and at least 90% of all components in the gel film. It is understood that up to 15%, 10% or 5% water may remain strongly associated with the solids in the dry gel film.
The gel films of the invention can also contain colorants and flavorants such as sugar, corn syrup, fructose, sucrose, etc, whether or not other components, such as plasticizers, bulking agents, second film formers, etc. are present. One embodiment of a gel film of the invention comprises the alginate described herein, flavorant and water in a high solids system; e.g., greater than 50%, 60%, 65%, 75%, 80%, 85%, 90% solids.
It is possible that the gel films of the present invention can contain non- thermoreversible gums. However, so as not to adversely impact the homogeneous and thermoreversible nature of the gel films of the present invention, such non- thβrmoreversible films should be present in an amount of less than 50% by weight of the alginate, preferably, less than 40%, more preferably, less than 30%. Examples of such nonthermoreversible gums include (e.g., crosslinked and partially crosslinked) gums such as calcium set (crosslinked) pectins or alginates. Calcium reactive alginates and pectins, as well as their less refined forms, are considered as thermoreversible gums in the absence of divalent cations. The films of the present invention are generally made from a process utilizing an apparatus that enables sufficiently high shear, temperature (above the gelling temperature) and residence time so as to provide a homogeneous molten mass of the composition and allow formation of the gel upon cooling. This is generally accomplished in the apparatus by heating, hydrating, mixing, solubilizing and optionally deaerating the composition. Examples of such an apparatus include Ross mixers, Stephan processors, extruders, jet cookers and the fluid mixing apparatus as set forth in Figure 1. Ross mixers, Stephan processors and conventional jet cookers are readily available commercially. Prior to cooling, the molten mass may optionally be fed to at least one of a pump, mixer or devolatilizer; e.g., s an extruder. Note, as an additional aspect of the invention, the molten mass need not necessarily reach homogeneity in step (i). That is, when an additional apparatus such as a mixer, pump and/or devolatilizer is used, homogeneity of the molten mass can be obtained prior to or after feeding the molten composition into at least one of the mixer, pump and/or devolatilizer provided the molten mass reaches homogeneity prior to gelling. An extruded molten mass can also be directed to a film forming or shaping device (e.g. spreader box) that aids in the uniform casting of a continuous film, or, through a die that allows a direct formation of a film or shaped extrudate from the molten mass delivery equipment. Care must be taken to maintain the molten mass above the initiation of restricted flow/gel structure formation. Insulated and pre-heated (to maintain proper temperatures) transfer hoses may be used to insure molten mass flow until desired gel film formation is initiated. Additional processing methods (such as pre-heating the discharge/plunger-like head as seen in a Ross process system) can force (by pressure) the molten mass through the transfer hoses mentioned above. Additional insulation can help maintain molten mass temperatures through the use of a Teflon disk initially placed upon the molten mass surface immediately after removing the mixing device. Note, as an additional aspect of the invention, the molten mass need not necessarily reach full homogeneity in step (i). That is, when an additional apparatus such as a mixer, pump and/or devolatilizer is used, homogeneity of the molten mass can be obtained prior to or after feeding the molten composition into at least one of the mixer, pump or devolatilizer provided the molten mass reaches homogeneity prior to gelling.
As used herein, a "fluid mixing apparatus" refers to the apparatus in FIG. 1. FIG. 1 illustrates a fluid mixing apparatus 10. The fluid mixing apparatus 10 is arranged to mix steam 2 with a first fluid or slurry 4 and a second fluid or slurry 6 to produce a molten mass or slurry mixture 8.
The fluid mixing apparatus 10 comprises a first housing 20 having a first inlet 22 through which the steam 2 enters the housing 22, a nozzle end 24 from which the steam 2 exits the housing 20, and a nozzle valve or stem 26 disposed at the nozzle end 24. An actuator means 30 is connected to the first housing 20 for controlling the exit rate or exit pressure of the first fluid 2 at the nozzle end 24. The actuator means 30 may be of the type manufactured by Fisher Controls U.S.A.
The fluid mixing apparatus 10 further comprises a second, mixing housing 40 coupled to the first housing 20 at the nozzle end 24 of the first housing 20. The second housing 40 includes a second inlet 42 through which the first fluid 4 enters the second housing 40, and a third inlet 44 through which the second fluid 6 enters the second housing 40. The inlets 42 and 44 are disposed downstream of the first inlet 22. As shown in FIG. 3, the second inlet 42 and third inlet 44 are disposed in a common plane and spaced apart radially from each other, most preferably directly opposite (i.e., 180° apart) about the central axis Y of the mixing apparatus 10. The second housing 40 defines a generally cylindrical mixing chamber 52 that in turn defines a flow passage extending along the axial length of the mixing chamber 52 from an entry end 54 of the mixing chamber 52 to an exit end 56 of the chamber 52. The nozzle valve 26 is movable by the actuator 30 between seated and unseated positions at the entry end 54 to control the flow rate of steam 2 into the mixing chamber 52.
The nozzle end 24 of the first housing 20 directs the steam 2 into the entry end 54 of the mixing chamber 52. The second inlet 42 and the third inlet 44 radially direct the first fluid 4 and second fluid 6, respectively, into the mixing chamber 52. The steam 2, first fluid 4 and second fluid 6 are mixed in the mixing chamber 52 to form a molten mass or mixture 8 which exits the mixing chamber 52. The molten mass 8 then may be shaped into a shaped article or formed into a film, such as by casting the mixture 8 onto a cooling drum or by passing the mixture 8 through an extruder.
The fluid mixing apparatus 10 is adapted to produce a mixture for forming a film, more particularly an edible film for making edible delivery systems. Incompatible film components generally are placed in different fluid inlet streams so that such incompatible components come together in the first instance at the interface of the steam injection within the mixing chamber 52 of the fluid mixing apparatus. While FIG. 1 shows inlets for steam, and first and second fluids, one or more additional inlets for one or more additional fluids may be provided. Preferably, the housings 20, 40 and other components of the fluid mixing apparatus 10 are constructed of high-grade stainless steel. The gel film can also be used to modify the dissolution profile of the dosage forms. For example, gel films of the invention can contain added components that can create solid dosage forms having immediate release, enteric or delayed release capabilities. Definitions of "immediate release", "delayed release" and "enteric" can be found in the U.S. Pharmacopeia and are incorporated herein by reference.
The present invention is now described in more detail by reference to the following examples, but it should be understood that the invention is not construed as being limited thereto. Unless otherwise indicated herein, all parts, percents, ratios and the like are by weight.
EXAMPLES
Unless otherwise indicated, the following procedures were used to prepare and evaluate the materials and films in Examples 1-3. The Stephan UMC5 processor is a laboratory scale mixing device that provided suitable high shear mixing, heating, and deaerating of the formulations which were cast as films in the laboratory. A suitable batch size used was 1500 grams.
An aqueous starch dispersion was prepared by dissolving any salts/buffers and pH modifiers in deionized water. The starch and/or maltodextrin (Ml 00) were added and mixed until dissolved/dispersed. Pure Cote® B760 starch is available from the Grain Processing Coiporation of Muscatine, Iowa. A hydrocoUoid mixture was prepared in the Stephan UMC5 processor by premixing the plasticizers until uniform, and adding the preblended dry hydrocoUoids portionwise while mixing for about 30 seconds at 200 rpm after each addition. Sorbitol Special and glycerin were used as plasticizers. Sorbitol Special is an aqueous solution of sorbitol and sorbitol anhydrides at 76% solids supplied by SPI Polyols, Inc. (New Castle, DE).
The starch dispersion was added to the non-aqueous hydrocoUoid mixture and mixed at 300 rpm for 5 minutes. The mechanical agitation was increased to 2100 rpm and the mixture was heated to 85°C to 95°C with mixing. When the target temperature was achieved, the mixture was stirred for 30 minutes, then the sample was held under vacuum (50-60 bars) with continued agitation for an addition 45 minutes.
When the hold time under vacuum at temperature has been completed, the sample was poured into a preheated wide mouth quart Mason jar. Temperature and pH were recorded. Viscosity was measured on the hot sample using an Brookfield LVF viscometer.
A small portion of the sample was set aside and refrigerated usually overnight prior to measurement of gel/melt properties and solids using an Atago E series hand held refractometer (Gardco, Pompano Beach, FL). The melt temperature was determined by placing a small chunk of the refrigerated gel on a wire string stand held within a test tube so that the chunk does not contact the wall of the test tube. The test tube was covered with aluminum foil with a small hole to allow measurement of the gel temperature using a digital tempermeter probe. The test tube was immersed in the heating bath so that the
chunk is below the surface of a hot water bath at approximately 100°C. A silicone oil
bath was used for samples that had melt temperatures above 90°C. The melt temperature was recorded when the gelled sample became wet in appearance, softened and could be stirred (a temperature range was noted). Once the sample had melted, the test tube was
transferred to a second beaker containing cold tap water (15°C). The temperature probe was used to record the temperature as the sample was cooled and to probe the sample surface to determine whether the sample had begun to gel. The gel temperature was the temperature upon cooling where the sample no longer flowed to fill in an indentation made by the probe.
The hot sample was then cast, using a draw down bar with a gap set at 3 mm clearance, onto 177 mm by 177 mm by 5 mm metal plates which were pre-sprayed with PAM (lecithin) to facilitate easy removal of film material. The gel coated plates were covered to avoid loss of moisture on the cast film and refrigerated (less than 8°C) for at least one-half hour prior to removal of the film for testing. Refrigeration is not required for film formation. Dried film strips were prepared by drying the coated plates in a 40°C forced air/fan oven. Films dried 2 hours at 40°C gave an intermediate solids of about 60% while films dried overnight at 40°C typically gave solids of 80% or higher. Test properties were measured at room temperature (about 20°C) unless otherwise indicated. The percent of solids in the dried film was determined by difference in weight between the cast film using its formulated solids and the dried film. Break force strengths were measured on the cast and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig.
Unless otherwise indicated, Maltrin Ml 00 was obtained from Grain Processing Corporation, Pure-Cote B760 was obtained from Grain Processing Corporation, Sorbitol Special was obtained from SPI Polyols and Glycerin was obtained from NWR (EP/USP grade). Example 1
Table I lists compositions and properties of gel films prepared using blends of sodium alginates with low viscosity guar Edicol ULN 50 obtained commercially from Indian Gum Industries Ltd.. Protanal® LFR 5/60, Protanal® LF 20/40 and Protanal® SF 120 RB are sodium alginates available from FMC Corporation (Philadelphia, PA).
Table I
Ex-1-1 Ex 1-2 Ex 1-3
Ingredient (grams)
Water 836.3 836.3 836.3
LFR 5/60 40.5 0 0
LF 20/40 0 40.5 0
SF120 RB 0 0 30
Guar ULV50 49.5 49.5 45
Starch B760 220.8 220.8 220.8
M100 0 0 15.0
Sorbitol SP 264.4 264.4 264.4
Glycerin 88.2 88.2 88.2
Total weight 1500.0 1500.0 1500.0
Temp, °C* 90 94 93 iscosity, mPas* 31,650 >50,000 >50,000
Gel, °C 50 RT RT
Melt, °C 70-71 95* 87*
PH 5.6 5.5 5.6
Cast Film
Solids, est 40% 40% 40% BF (g) <40 102 110
Dried film (2 hrs@ 40°C)
Solids, est 60% 64% 67% BF (g) 617 1250 1126
Dried film (16 hours, 40 C)
Solids, est 80% 80% 94%
Avg film thickness 0.53 0.89 0.51
BF (g) 4780 7701 10,850
* Temperature and viscosity of molten mass prior to casting Increasing the molecular weight of the sodium alginate contributed to the overall film structure and resulted in increased film strength (Examples 1-1, 1-2 and 1-3). The melt temperatures above were measured by heating the gel films using an oil bath. When heated, they soften and could be stirred. When allowed to cool, the gel formed above room temperature.
Example 2
Two potassium alginates were used: KAHG was the potassium salt of alginic acid extracted from Laminaria hyperborean and contains a high level guluronic acid (G) units. KAHM was a potassium salt of alginic acid extracted from Lessonia nigrescens and has a high level of mannuronic (M) units. The viscosity of the KAHG and KAHM were 5 cps and 12 cps, respectively, when measured in a 1% solution of water at 25°C.
Potassium cation associated with the alginate is beneficial for the initiation of the structuring of kappa carrageenan and/or kappa-2 carrageenan with the alginate into a homogeneous cast & set film. The kappa carrageenan was an alkali processed, clarified extract of Kappaphycus alaverei {Eucheuma cottonii). All hydrocoUoids used had low levels of divalent cations as shown in Table II.
Table II: Cation Content of HydrocoUoids
Test KAHG KAHM Kappa Cgn
Viscosity
Mg, % 0.07 0.12 0.09
Ca, % 0 0 0.06
K, % 15.73 16.01 2.60
Na, % 0.63 0.59 5.45 Table III presents compositions and properties of films formed using mixtures of potassium alginates and other film formers such as kappa carrageenan and low viscosity guar gum available as Edicol ULV 50 from Indian Gum Industries.
Table III: FUms Using Low Viscosity Guar, Potassium Alginates and Carrageenan
Ex 2-1 Ex 2-2 Ex 2-3 Ex 2-4 Ex 2-5 Ex 2-6
Ingredient (g)
Water 836.3 836.3 836.3 836.3 836.3 836.3
KAHG 60 60 40.5 10.5 0 0
KAHM 0 0 0 0 60.0 10.5
Kappa Cgn 30 30 0 30 30.0 30
Guar 0 0 49.5 49.5 0 49.5
Starch B760 220.8 220.8 220.8 220.8 220.8 220.8
Sorbitol SP 264.4 264.4 264.4 264.4 264.4 264.4
Glycerin 88.2 88.2 88.2 88.2 88.2 88.2
Total weight 1500.0 1500.0 1500.0 1500.0 1500.0 1500.0
Temp, °C* 90 90 88 90 93 92
Viscosity, 26,500 28,650 24,800 28,250 42,650 31,250 mPas*
Gel, °C 42 41 50-51 53 39 55
Melt, °C 60-65 62-67 60-61 70-74 60-63 65-69
PH 7.6 7.2 6.3 5.6 7.4 5.9
Cast Film
Solids, est 40% 40% 40% 40% 38% 41%
BF (g) <40 <40 <40 188 <40 185
Dried film
(2 hrs@ 40°C)
Solids, est 66% 62% 63% 64% 62% 66%
BF (g) 370 248 445 1811 502 1265
Dried film (16 hours, 40C)
Solids, est 81% 79% 85% 80% 77% 80%
Avg film 0.83 0.76 0.56 0.60 0.56 0.59 thickness (mm)
BF (g) 3826 4253 4144 7960 6918 8301
Temperature and viscosity of the molten mass prior to casting Results indicate beneficial interaction by combining potassium alginate, either high guluronic or high mannuronic, or combinations thereof, with kappa carrageenan and guar. Further variation of weight ratios of alginate and second film formers and process variations can also be used to, again, either cast as a high solids (>80%) molten mass, formed, and cooled gel film as is or for further processing.
Example 3
Table IN lists compositions and properties of gel films prepared using propylene glycol alginate and kappa carrageenan. Protanal® ester BN4830 is a propylene glycol alginates available from FMC Corporation (Philadelphia, PA). HEC is hydroxyethylcellulose. Kappa carrageenan is described above in Example 2.
Table IV: Propylene Glycol Alginate-based Blend Compositions
Ingredient (g) 3-1 3-2 3-3
Water 840.3 836.3 840.3
BN4830 91.2 49.5 66.0
HEC 1.9
Kappa cgn 24.0 40.5 54.0
K citrate 2.9
Starch B760 207.8 220.8 207.8
Sorbitol SP 264.4 264.4 248.8
Glycerin 88.2 88.2 83
Temp, °C* 91 87 89
Viscosity, mPas* 24,800 6550 12500 pH 4.2 3.8 3.9
Gel, °C 59 42-43 43-44
Melt, °C 72-75 54-63 62-64
Cast film
Solids, est. 45% 38% 36%
BF (g) 136 89 113
Dried @ 16 hours,
40°C
Solids 87% 79.8 86.6 Ingredient (g) 3-1 3-2 3-3
Avg film thickness 0/72 0U8 0.79
(mm)
BF (g) 8838 5244 7638
* Temperature and viscosity of molten mass prior to casting
Table V reports compositions and film properties for kappa-2 carrageenan used in combination with propylene glycol alginate and potassium alginate. The kappa-2 carrageenan was an alkali processed, clarified extract of a mixture of Gigartina skottsbergii and Sarcothalia crispata, primarily haploid (gametophyte) plants. About 10- 20% (total) of lambda- and theta-carrageenans from diploid (tetrasporophyte) plants were also present.
Table V: Alginate Films With Kappa-2 Carrageenan
Figure imgf000024_0001
Ingredient (g)
Water 834.7 834.7
Kappa-2 Cgn 40.5 54.0
KAHG 31.5 36
BV4830 18.0 36.0
M-100 227.3 227.3
Sorbitol SP 272.2 272.2
Glycerin 90.8 90.8
Temp,°C* 87 84
Viscosity, mPas* 4250 1050
Solids 40 37
Melt,°C 77-78 74-79
Gel,°C 54 52 pH 4.8 5.5
Cast film
(est 40% solids)
BF (g) 142 168
Dried film
(est 80% solids) Ex 3-4 Ex 3-5
Ingredient (g)
16 hours, 40C Avg film thickness 0.67 0.48
BF (g) 3409 4004
Temperature and viscosity of molten mass prior to casting
In example 3-4, potassium cations are supplied by the potassium alginate. The potassium cations promote carrageenan double helix formation at a temperature that allows the carrageenan to form its gel film structure. In example 3-5, the additional strength and lower processing viscosity is due to the higher level of propylene glycol alginate.
Table VI presents compositions and gel films formed from low viscosity guar Edicol ULV 50 in combination with propylene glycol alginate and other hydrocoUoids. Protanal® ester BV4830 and Protanal® ester SLF3 are propylene glycol alginates available from FMC Corporation (Philadelphia, PA) and Kibun, respectively. The SLF-3 has a lower molecular weight compared to the BV-4830. HEC is hydroethylcellulose.
Table VI: Films using Propylene Glycol Alginate with Guar
Ex 3-6 Ex 3-7 Ex 3-8 Ex 3-9
Ingredient (g)
Water 840.3 840.3 840.3 836.3
BV4830 0 0 91.2 12.0
SLF-3 114 85.5 0 0
HEC 2.4 1.8 1.9 0
Kappa cgn 0 0 24 40.5
GUAR ULV 50 0 30 0 37.5
Starch B760 207.8 207.8 207.8 220.8
M-100 0 0 0 0
Na citrate 3.6 2.7 0 0
K citrate 0 0 2.9 0
KC1 0 0 2.4 0 Ex 3-6 Ex 3-7 Ex 3-8 Ex 3-9
Ingredient (g)
Sorbitol SP 248.8 248.8 248.8 264.4
Glycerin 83 83.0 83.0 88.2
Temp, °C* 91 87 90 90
Viscosity, mPas* 3250 16,500 25,000 23,100
Gel, °C 34-35 34-38 43-46 46
Melt, °C 58-60 62-64 56-62 60-68
PH 4.4 4.5 4.3 4.6
Cast Film
Solids, est 39% 41 45% 41.5% BF (g) <40 <40 231 147
Dried film (2 hrs@ 40°C)
Solids, est 74% 65% 55% 60% BF (g) 1877 355 842 592
Dried film (16 hours, 40C)
Solids, est 85% 77% 78% 80%
Avg film thickness 0.67 0.60 0.75 0.62
(mm)
BF (g) 4677 3317 9599 7214
Temperature and viscosity of molten mass prior to casting
Example 4
The following examples show films made using the fluid mixing apparatus of Figure 3. In these examples, Part A and Part B were pumped from separate holding tanks at ambient temperature, as two separate streams 4, 6, into two different inlet ports 42, 44 which fed the steam injection fluid mixing apparatus device 10. The two individual streams 4, 6 were combined at the interface of the steam in the mixing zone 52 of the fluid mixing apparatus 10. The separate solutions of Part A and Part B were readily pumped into the fluid mixing apparatus 10 and mixed with steam 2. The steam 2 was introduced to the mixing zone at a pressure of 120 psi. The resulting molten mass or slurry mixture 8 flowed out of the exit port 56 of the fluid mixing apparatus 10. The mixture 8 was poured onto a smooth surface and drawn down to form a homogeneous film 9.
To measure the viscosity of the mixture 8, approximately 500 ml sample of the mixture 8 was collected from the outlet 56 and poured into a jar. The temperature, pH and viscosity were measured for this sample at 95°C. A Brookfield LVF viscometer was used to measure the viscosity. An appropriate speed and spindle combination were used such that a reading could be taken. The dial reading was converted to dynamic viscosity (cP).
To measure the film strength and solids level, the molten mass 8 was collected from the outlet 56 then cast using a draw down bar, with a gap set at 3 mm, onto a stainless steel metal plate. The initial films 9 or "fresh films" were collected. Portions of the fresh films 9 were dried by placing them in a 40°C forced air oven. Break force was measured on the fresh and dried film strips using a Texture Analyzer TA-108S Mini Film Test Rig. The percent solids were determined by measuring the difference between the initial weight of the fresh film and the final weight of the dried films.
To measure the gel temperature, a portion of the molten mass 8 was collected from the outlet 56 of the mixing apparatus 10 and transferred to a test tube. Half of the test tube remained empty. A glass thermometer was inserted into the molten mass 8. The material 8 was allowed to cool under room temperature conditions. After each degree of cooling, the thermometer was removed from the material 8. When a small, temporary indentation was observed in the surface of the mass 8, this temperature was recorded. The thermometer was re-inserted into the mass 8, which was allowed to cool further. The thermometer was removed and re-inserted at every degree of cooling until such a time as a permanent indentation formed in the mass 8, such that the indentation did not refill. The temperature at which the permanent indentation formed was recorded. The gel temperature reported was the range between the two recorded temperatures.
Table VII - Mixtures Containing PGA
Figure imgf000028_0001
Table VII shows that the film former can be a combination of hydrocoUoids, such as carrageenan and PGA. Additionally, salts can be added to influence film properties such as strength, gel temperature and pH.
The following Tables VIII and LX provide further descriptions of the components specified in the above examples. Table VIII - Component Descriptions
Figure imgf000029_0001
The following Table IX provides a description of the various carrageenans used in this example.
Table IX - Carrageenan Descriptions
Figure imgf000029_0002
Example 5
Delivery films of the invention were prepared by the following method: alginate and kappa carrageenan were dry blended to form a gum blend. KAHG and NAHG were the potassium salt and the sodium salt, respectively, of alginic acid extracted from Laminaria hyperborean and contains a high level guluronic acid (G) units. KAHM was a potassium salt of alginic acid extracted from Lessonia nigrescens and has a high level of mannuronic (M) units. The 1% aqueous solutions of the KAHG and KAHM had a viscosity of 5 cP and 12 cP, respectively, when measured in a 1% solution of water at 25°C. Maltrin M 100 maltodextrin (Grain Processing Corp., Muscatine, Iowa) was dry blended with the gum blend. Deionized water and glycerin were weighed into a 1.2 liter stainless steel beaker. The dry premix was added to the water with good agitation, then heated to 90 °C and held within the temperature range 90°C to 95°C for 15 minutes to fully hydrate the gums. After replacing any water loss due to evaporation, the delivery ingredient was added and mixed two minutes for dispersion. The delivery ingredients tested were: (1) natural and artificial strawberry flavor (Dragoco, 0.1%), (2) titanium dioxide, and (3) caffeine. The hot solution was quickly poured into containers. Solution cast in petri dishes was cooled to room temperature to form films, then dried overnight in a forced draft oven at 45 °C to a constant weight. A sample was cooled then refrigerated (less than 8°C) overnight prior to measurement of gel/melt properties and solids using an Atago E series hand held refractometer (Gardco, Pompano Beach, FL). The melt temperature was determined by placing a small chunk of the refrigerated gel on a wire string stand held within a test tube so that the chunk did not contact the wall of the test tube. The test tube was covered with aluminum foil with a small hole to allow measurement of the gel temperature using a digital tempermeter probe. The test tube was immersed in the heating bath so that the chunk is below the surface of a hot water bath at
approximately 100°C. A silicone oil bath was used for samples that had melt
temperatures above 90°C. The melt temperature was recorded when the gelled sample became wet in appearance, softened and could be stirred (a temperature range was noted). Once the sample had melted, the test tube was transferred to a second beaker containing
cold tap water (15°C). The temperature probe was used to record the temperature as the sample was cooled and to probe the sample surface to determine whether the sample had begun to gel. The gel temperature was the temperature upon cooling where the sample no longer flowed to fill in an indentation made by the probe. Break force (BF) and penetration were measured on the cast and dried film strips using a Texture Analyzer TA- 108S Mini Film Test Rig. Rigidity was calculated as the BreakForce divided by the penetration.
Table X: Alginate Delivery Systems
Figure imgf000031_0001
Figure imgf000032_0001
While the invention has been described in detail and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.

Claims

WHAT IS CLAIMED IS:
1. A delivery system comprising a homogenous, theraioreversible gel film, wherein said gel film comprises: (i) a film forming amount of a water soluble thermoreversible alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent; and (ii) an active substance.
2. The delivery system of claim 1, wherein said active substance is at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, cosmetic ingredient, agricultural active, a vitamin, a mineral, a coloring agent, a sweetener, a flavorant, a fragrance or a food.
3. The delivery system of claim 1, wherein said alginate is present in an amount of at least 0.25% by dry weight of the gel film.
4. The delivery system of claim 1, wherein said alginate is present in an amount of 0.25% to 25% by dry weight of the gel film.
5. The delivery system of claim 1, wherein said alginate is present in an amount of at least 10% of the total dry weight of film formers in the gel film.
6. The delivery system of claim 1 , wherein said alginate is present in an amount of at least 40% of the total dry weight of film formers in the gel film.
7. The delivery system of claim 1 , wherein said alginate is present in an amount of at least 60% of the total dry weight of film formers in the gel film.
8. The delivery system of claim 1, wherein said alginate is present in an amount of at least 80% of the total dry weight of film formers in the gel film.
9. The delivery system of claim 1, wherein said alginate is the only film former present in the gel film.
10. The delivery system of claim 1, wherein said second film former is selected from the group consisting of starch, starch derivative, starch hydrozylate, cellulose gums, kappa carrageenan, iota carrageenan, polymannan gums, dextrans, pullulan, gellan, pectin, alkylcellulose ethers and modified alkyl cellulose ethers.
11. The delivery system of claim 1, wherein said plasticizer is at least one member selected from the group consisting of glycerin, sorbitol, maltitol, lactitol, solubilized oil, and polyalkylene glycols; said second film former is at least one member selected from the group consisting of a starch, starch derivative, starch hydrozylate, cellulose gum, kappa carrageenan, iota carrageenan, polymannan gums, dextran, pullulan, gellan, pectin, an alkylcellulose ether and a modified alkyl cellulose ether; and said bulking agent is at least one member selected from the group consisting of microcrystalline cellulose, microcrystalline starch, starch, starch derivatives, inulin, and starch hydrozylates.
12. The delivery system of claim 1 having a break force strength of at least 2,500 grams.
13. The delivery system of claim 1 having a break force strength of at least 4,000 grams.
14. The delivery system of claim 1 having a break force strength of at least 5,000 grams.
15. The delivery system film of claim 1 having a break force strength of at least 6,000 grams.
16. A process for preparing the homogeneous gel film delivery system in any of claims 1-15 comprising the steps of:
(i) heating, hydrating, mixing, solubilizing and optionally de-aerating said alginate and optionally at least one of a plasticizer, a second film former, a bulking agent, and a pH controlling agent in an apparatus providing sufficient shear, temperature and residence time to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature of said composition;
(ii) adding an effective amount of an active substance either prior to or after formation of the molten composition; and (iii) cooling said molten composition containing said active substance at or below its gelling temperature to form said gel films containing said active substance.
17. The process of claim 16, wherein said active substance is at least one of an oral care agent, a breath freshening agent, a pharmaceutical agent, a nutraceutical agent, a salivary stimulant agent, a vitamin, a mineral, a cosmetic ingredient, an agricultural active, a coloring agent, a sweetener, a flavorant, a fragrance, a food.
18. The process of claim 16, wherein said apparatus is a Ross mixer, extruder, Stephan processor, jet cooker or fluid mixing apparatus.
19. The delivery system of claim 1 having a break force strength of at least 250 grams.
20. The delivery system of claim 1 having a break force strength of at least 1,000 grams.
21. The delivery system of claim 1 , further comprising a flavorant and having a solids content of at least 50%.
22. The delivery system of claim 1, wherein said second film former is a carrageenan having a viscosity of less than 10 cps at 75 °C when measured in a 0.10 molar aqueous sodium chloride solution containing 1.5% by weight of said carrageenan based on the weight of all components in said solution.
PCT/US2004/011600 2003-04-14 2004-04-14 Delivery systems of homogeneous thermoreversible alginate films WO2004091528A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2006510060A JP2007525451A (en) 2003-04-14 2004-04-14 Uniform and thermoreversible alginate film delivery system
BRPI0409336-4A BRPI0409336A (en) 2003-04-14 2004-04-14 release system comprising a thermoreversibly, homogeneous gel film, release system film, and process for preparing the release system thereof
EP04759551A EP1622588A2 (en) 2003-04-14 2004-04-14 Delivery systems of homogeneous thermoreversible alginate films

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US46272103P 2003-04-14 2003-04-14
US46278303P 2003-04-14 2003-04-14
US46279303P 2003-04-14 2003-04-14
US46279203P 2003-04-14 2003-04-14
US46279403P 2003-04-14 2003-04-14
US46278503P 2003-04-14 2003-04-14
US46261703P 2003-04-14 2003-04-14
US46275803P 2003-04-14 2003-04-14
US60/462,792 2003-04-14
US60/462,758 2003-04-14
US60/462,721 2003-04-14
US60/462,617 2003-04-14
US60/462,785 2003-04-14
US60/462,783 2003-04-14
US60/462,794 2003-04-14
US60/462,793 2003-04-14

Publications (3)

Publication Number Publication Date
WO2004091528A2 true WO2004091528A2 (en) 2004-10-28
WO2004091528A3 WO2004091528A3 (en) 2005-01-27
WO2004091528B1 WO2004091528B1 (en) 2005-03-24

Family

ID=33304300

Family Applications (9)

Application Number Title Priority Date Filing Date
PCT/US2004/011906 WO2004091537A2 (en) 2003-04-14 2004-04-14 Process for making gel films
PCT/US2004/011561 WO2004091527A2 (en) 2003-04-14 2004-04-14 Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films
PCT/US2004/011907 WO2004091538A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible alginate films and soft capsules made therefrom
PCT/US2004/011632 WO2004091533A2 (en) 2003-04-14 2004-04-14 Delivery systems of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
PCT/US2004/011602 WO2004091530A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
PCT/US2004/011601 WO2004091529A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
PCT/US2004/011600 WO2004091528A2 (en) 2003-04-14 2004-04-14 Delivery systems of homogeneous thermoreversible alginate films
PCT/US2004/011908 WO2004091539A2 (en) 2003-04-14 2004-04-14 Fluid mixing methods and apparatus
PCT/US2004/011631 WO2004091532A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom

Family Applications Before (6)

Application Number Title Priority Date Filing Date
PCT/US2004/011906 WO2004091537A2 (en) 2003-04-14 2004-04-14 Process for making gel films
PCT/US2004/011561 WO2004091527A2 (en) 2003-04-14 2004-04-14 Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films
PCT/US2004/011907 WO2004091538A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible alginate films and soft capsules made therefrom
PCT/US2004/011632 WO2004091533A2 (en) 2003-04-14 2004-04-14 Delivery systems of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
PCT/US2004/011602 WO2004091530A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
PCT/US2004/011601 WO2004091529A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2004/011908 WO2004091539A2 (en) 2003-04-14 2004-04-14 Fluid mixing methods and apparatus
PCT/US2004/011631 WO2004091532A2 (en) 2003-04-14 2004-04-14 Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom

Country Status (10)

Country Link
US (3) US20050084516A1 (en)
EP (8) EP1620114A2 (en)
JP (8) JP2007525451A (en)
KR (4) KR101128201B1 (en)
BR (7) BRPI0409336A (en)
CA (5) CA2522293A1 (en)
IL (1) IL171291A (en)
MX (4) MXPA05011028A (en)
PL (1) PL1628643T3 (en)
WO (9) WO2004091537A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073346A1 (en) * 2005-12-23 2007-06-28 Kjell Stenberg Water-soluble films comprising low-viscosity alginates
JP2008072915A (en) * 2006-09-19 2008-04-03 Dhc Co Film-like food
US10814005B2 (en) * 2013-04-02 2020-10-27 Paxtree Ltd. Composition as auxiliary means for oral medication

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7887838B2 (en) * 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
KR101128201B1 (en) * 2003-04-14 2012-03-23 에프엠씨 코포레이션 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
TW200502004A (en) * 2003-05-02 2005-01-16 Hayashibara Biochem Lab Soft capsule film and soft capsule
US20050196437A1 (en) * 2004-03-02 2005-09-08 Bednarz Christina A. Hard capsules
US7494667B2 (en) * 2004-03-02 2009-02-24 Brunob Ii B.V. Blends of different acyl gellan gums and starch
DE102005023258A1 (en) * 2004-11-16 2006-11-23 Fan Separator Gmbh Rotary drum for aerobic heating of free-flowing solids
WO2007075422A2 (en) * 2005-12-27 2007-07-05 Monosol Rx, Llc Ph modulated films for delivery of actives
DK3095447T3 (en) 2006-02-03 2022-01-31 Opko Renal Llc TREATMENT OF VITAMIN D INSUFFICIENTS AND DEFICIENCY WITH 25-HYDROXYVITAMIN D2 AND 25-HYDROXYVITAMIN D3
US8262820B2 (en) 2006-04-28 2012-09-11 United States Gypsum Company Method of water dispersing pregelatinized starch in making gypsum products
US20070281065A1 (en) * 2006-06-06 2007-12-06 Modliszewski James J Kappa-2 carrageenan composition and products made therefrom
CA2660613A1 (en) * 2006-06-06 2007-12-21 Fmc Corporation Kappa-2 carrageenan composition and products made therefrom
CA2655499C (en) 2006-06-21 2015-10-27 Proventiv Therapeutics, Llc Method of treating and preventing secondary hyperparathyroidism_with vitamin d repletion and vitamin d replacemnt therapies
US8900558B2 (en) 2006-06-30 2014-12-02 Colgate-Palmolive Company High fluoride ion oral care composition and method for maintaining anticaries activity
KR100846494B1 (en) * 2006-09-26 2008-07-17 삼성전자주식회사 Primer set for amplifying target sequences of Helicobacter pylori method for detecting Helicobacter pylori using the primer set and kit for detecting Helicobacter pylori comprising the primer set
US8574624B2 (en) * 2006-11-17 2013-11-05 Corn Products Development, Inc. Highly inhibited starch fillers for films and capsules
JP5379121B2 (en) * 2007-04-05 2013-12-25 ユニバーシティ・オブ・カンザス Fast dissolving pharmaceutical composition comprising pullulan
US8900629B2 (en) 2007-04-05 2014-12-02 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
ES2403107T3 (en) 2007-04-25 2013-05-14 Cytochroma Inc. Vitamin D insufficiency and deficiency treatment method
EP3542792B1 (en) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Controlled release 25-hydroxyvitamin d
JP5871447B2 (en) * 2007-11-30 2016-03-01 花王株式会社 GIP secretion inhibitor
US8236747B2 (en) * 2008-02-08 2012-08-07 Method Products, Inc. Consumer product packets with enhanced performance
CN106853250A (en) 2008-04-02 2017-06-16 赛特克罗公司 Method, composition, purposes and kit for vitamin D deficiency and associated disorders
US8097047B2 (en) * 2008-04-02 2012-01-17 The Procter & Gamble Company Fabric color rejuvenation composition
EP2108677A1 (en) 2008-04-10 2009-10-14 Swiss Caps Rechte und Lizenzen AG Thermoplastic starch-containing materials
PL2303034T3 (en) * 2008-07-25 2017-03-31 Tic Gums Inc Gum arabic replacements in: 1) panning, confections, adhesion & coatings; 2) edible films and flavor encapsulation; and 3) lithography
ITMI20081450A1 (en) * 2008-08-04 2010-02-05 Biofarmitalia Spa SOLID RAPID DISSOLUTION FILM IN LIQUIDS
US8303159B2 (en) * 2008-09-05 2012-11-06 United States Gypsum Company Efficient wet starch preparation system for gypsum board production
KR101361952B1 (en) * 2008-09-26 2014-02-11 가부시키가이샤 산쿄 Process for producing soft capsule and apparatus for producing the same
FR2946227B1 (en) * 2009-06-03 2011-07-22 Ds France Sas SAUCISING COATING COMPRISING BOTH A CELLULOSE DERIVATIVE AND A GALACTOMANNAN.
JP4822299B2 (en) * 2009-06-19 2011-11-24 富士カプセル株式会社 Soft capsule and method for producing the same
KR101760534B1 (en) * 2009-09-10 2017-07-21 에프엠씨 코포레이션 Seamless alginate capsules
US20110236465A1 (en) * 2010-03-26 2011-09-29 Hall Mark J Melt-extruded film
CN105796530A (en) 2010-03-29 2016-07-27 赛特克罗公司 Methods and compositions for reducing parathyroid levels
ES2651933T3 (en) * 2010-07-19 2018-01-30 Procaps S.A. Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
US9277976B2 (en) 2011-01-24 2016-03-08 Leonard G. Lorch Dental floss
US9277977B2 (en) 2011-01-24 2016-03-08 Leonard G. Lorch Dental floss
US10206765B2 (en) 2011-01-24 2019-02-19 Leonard G. Lorch Dental floss
JP5597770B2 (en) 2011-04-20 2014-10-01 サフン カプセル カンパニー, リミテッド Non-animal soft capsule coating composition with improved disintegration and coating hardness
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
US9320297B2 (en) * 2012-03-22 2016-04-26 Lemniscate Innovations Llc Spherification/reverse spherification automated and integrated system and method
JP6082119B2 (en) * 2012-10-26 2017-02-15 ダウ グローバル テクノロジーズ エルエルシー Aqueous fragrance release gel
MX2015011163A (en) * 2013-03-15 2016-02-17 Banner Life Sciences Llc Non-gelatin enteric soft capsules.
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
US20160304761A1 (en) * 2013-12-05 2016-10-20 Empire Technology Development Llc Thermostatic materials, methods of making, and uses thereof
KR20170047265A (en) 2014-08-07 2017-05-04 옵코 아일랜드 글로벌 홀딩스 리미티드 Adjunctive therapy with 25-hydroxyvitamin d
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
EP3436026A1 (en) 2016-03-28 2019-02-06 OPKO Ireland Global Holdings, Ltd. Methods of vitamin d treatment
KR101973057B1 (en) * 2017-04-13 2019-04-26 주식회사 케이티앤지 Capsule for cosmetics and method of menufacturing thereof
KR101874512B1 (en) * 2017-06-29 2018-07-04 농업회사법인(주)강림오가닉 Soft Capsules method with mixture of Vegetable Omega-3 in Perilla Oil and Vitamin C and Soft Capsules
US11896720B2 (en) 2017-09-26 2024-02-13 Captek Softgel International Orally available articles containing at least one stabilized supplement therein
US10711119B2 (en) 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
GB201903090D0 (en) * 2019-03-07 2019-04-24 Cambridge Entpr Ltd Plant based functional materials
CN110075081A (en) * 2019-06-12 2019-08-02 江苏艾兰得营养品有限公司 A kind of soft capsule and preparation method thereof and purposes
CN111388442A (en) * 2020-03-24 2020-07-10 广州普正生物科技有限公司 Gel candy type plant soft capsule
WO2022066546A1 (en) 2020-09-22 2022-03-31 Swimc Llc Chitosan-containing coating compositions
KR102294072B1 (en) * 2020-11-19 2021-08-26 (주)알피바이오 Composition for plant-based chewable soft capsule and plant-based chewable soft capsule using the same
AU2022211416A1 (en) 2021-01-25 2023-07-06 Dupont Nutrition Biosciences Aps A stabilizer composition comprising microcrystalline cellulose
FR3122575A1 (en) * 2021-05-05 2022-11-11 Gabrielle De La Goublaye De Nantois Cosmetic soft capsules
WO2023008567A1 (en) * 2021-07-30 2023-02-02 三生医薬株式会社 Capsule shell composition and capsule obtained using same
EP4392527A1 (en) * 2021-08-27 2024-07-03 Unilever IP Holdings B.V. Films and capsules
EP4392534A1 (en) * 2021-08-27 2024-07-03 Unilever IP Holdings B.V. Films and capsules
WO2023025728A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025917A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025769A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023025649A1 (en) * 2021-08-27 2023-03-02 Unilever Ip Holdings B.V. Films and capsules
WO2023072546A1 (en) * 2021-10-25 2023-05-04 Unilever Ip Holdings B.V. Films and capsules
WO2024080269A1 (en) * 2022-10-11 2024-04-18 アリメント工業株式会社 Chewy soft capsule

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018365A2 (en) * 1998-09-25 2000-04-06 Warner-Lambert Company Fast dissolving orally consumable films
WO2002043657A2 (en) * 2000-11-30 2002-06-06 Wm. Wrigley Jr. Company Improved pullulan free edible film compositions and methods of making the same

Family Cites Families (174)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US348669A (en) 1886-09-07 John p
NL102330C (en) 1953-06-10
US2802000A (en) 1953-08-13 1957-08-06 Nat Starch Products Inc Ungelatinized cold water soluble starch ethers
US2825727A (en) * 1954-05-19 1958-03-04 Nat Starch Products Inc Ungelatinized starch products of improved properties and method of making the same
US2876217A (en) 1956-12-31 1959-03-03 Corn Products Co Starch ethers containing nitrogen and process for making the same
US3094517A (en) * 1958-12-29 1963-06-18 Marine Colloids Inc Process for treating a polysaccharide of seaweeds of the gigartinaceae and solieriaceae families
NL258156A (en) * 1959-12-01
US3058827A (en) * 1960-02-09 1962-10-16 Eastman Kodak Co Dialdehyde starch as gelatin hardener
US3176003A (en) * 1961-08-15 1965-03-30 Marine Colloids Inc Selective extraction of hydrocolloid fractions from sea plants
US3378546A (en) * 1965-03-03 1968-04-16 American Maize Prod Co Hydroxypropyl starch ether
US3505110A (en) 1967-01-18 1970-04-07 Penick & Ford Ltd Sugar products prepared from hydroxypropylated starch
US3499962A (en) * 1967-08-24 1970-03-10 Nat Starch Chem Corp Encapsulation of water insoluble materials
US3460717A (en) * 1967-10-16 1969-08-12 Burger Chef Systems Inc Mixing assembly for a dispenser
US3607394A (en) 1969-05-29 1971-09-21 Felix Joseph Germino Novel pregelatinized starches and process for preparing same
US3849395A (en) * 1971-08-25 1974-11-19 Marine Colloids Inc Degraded modified seaweed extractive and compositions containing same and their production
US3865603A (en) * 1972-07-17 1975-02-11 Nat Starch Chem Corp Modified starch-extended gelatin compositions
US4009291A (en) * 1974-03-25 1977-02-22 General Foods Corporation Cold water soluble stable bulked starch
US3956173A (en) 1974-07-05 1976-05-11 Hercules Incorporated Preparation of gels based on carrageenan
CA1045936A (en) * 1975-03-24 1979-01-09 Frederick W. Comer Clear, elastic, water gels based on carrageenan
US4129134A (en) 1975-04-14 1978-12-12 Philip Morris Incorporated Smoking article
US4026986A (en) 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
US4096327A (en) 1977-01-05 1978-06-20 Fmc Corporation Modified kappa-carrageenan
US4231803A (en) 1978-05-22 1980-11-04 Anheuser-Busch Incorporated Starch adhesive composition containing an oxidized waxy starch ester
US4276320A (en) * 1980-01-25 1981-06-30 Fmc Corporation Compositions and method for preparing dessert gels
JPS56167703A (en) * 1980-04-09 1981-12-23 Fmc Corp Sea weed eucheumacottonii denatured extract
US4443486A (en) * 1980-04-09 1984-04-17 Fmc Corporation Modified extractive of Eucheuma cottonii seaweed and composition containing same
FR2508051B1 (en) * 1981-06-23 1986-12-05 Roquette Freres COMPOSITION AND METHOD FOR FORMING A TEMPORARY PROTECTIVE COATING AND OBJECT THUS PROTECTED
FR2540153B1 (en) 1982-10-12 1987-02-13 Roquette Freres COMPOSITION AND METHOD FOR COATING PAPER AND CARDBOARD, PROCESS FOR PREPARING THE COMPOSITION AND PAPER AND CARDBOARD THUS OBTAINED
JPS6055039A (en) * 1983-09-07 1985-03-29 Mitsubishi Acetate Co Ltd Water-soluble polysaccharide film
JPS6088047A (en) 1983-10-21 1985-05-17 Kohjin Co Ltd Preparation of highly absorptive polymer
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
JPS6110508A (en) * 1984-06-26 1986-01-18 Mitsubishi Acetate Co Ltd Capsule and its production
US4828841A (en) 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4626288A (en) * 1985-01-10 1986-12-02 National Starch And Chemical Corporation Starch derivatives forming reversible gels
US4615897A (en) 1985-02-25 1986-10-07 Nabisco Brands, Inc. Cold water soluble gelatin
US4795642A (en) 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
GB8628068D0 (en) * 1986-11-24 1986-12-31 Unilever Plc Aqueous gel comprising carrageenan
FR2608456B1 (en) 1986-12-18 1993-06-18 Mero Rousselot Satia MICROCAPSULES BASED ON GELATIN AND POLYSACCHARIDES AND PROCESS FOR OBTAINING THEM
JPS63164858A (en) * 1986-12-27 1988-07-08 Unie Koroido Kk Outer coat of soft capsule
US4851394A (en) 1986-12-30 1989-07-25 Uni Colloid Kabushiki Kaisha Glucomannan/polyhydric alcohol composition and film prepared therefrom
US4808707A (en) 1987-06-08 1989-02-28 University Of Delaware Chitosan alginate capsules
JPS6416563A (en) * 1987-07-10 1989-01-20 Toyo Suisan Kaisha Production of sheet-shaped food
JPH0259513A (en) * 1988-08-24 1990-02-28 Kiyuukiyuu Yakuhin Kogyo Kk Oral cavity mucosa-attaching type halitosis-preventing agent
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5366755A (en) * 1989-02-10 1994-11-22 Maritta Timonen Foodstuffs containing novel degraded cellulose derivatives
US5089307A (en) * 1989-05-23 1992-02-18 Mitsubishi Rayon Co., Ltd. Edible film and method of making same
JPH02308760A (en) * 1989-05-23 1990-12-21 Mitsubishi Rayon Co Ltd Edible film and preparation thereof
NZ234361A (en) 1989-07-11 1991-09-25 Warner Lambert Co Polymer base-blend compositions containing destructurised starch and hydrolysed vinyl esters
CN1042439C (en) 1989-07-18 1999-03-10 沃纳-兰伯特公司 Polymer base blend compositions containing destructurized starch
KR910002990A (en) 1989-07-18 1991-02-26 토마스 디. 몰리터노 Polymer Based Mixing Composition Containing Degraded Starch
KR0178390B1 (en) 1989-07-20 1999-05-15 토마스 디. 몰리터노 Polymer base blend compositions containing destructured starch
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
JPH0647530B2 (en) * 1990-02-03 1994-06-22 ユニコロイド株式会社 Pharmaceutical capsules for intestinal diseases and method for producing the same
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
DE4018247A1 (en) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts MANUFACTURING METHOD FOR QUICK-DISINFITTING FILM-SHAPED PHARMACEUTICAL FORMS
GB9017800D0 (en) 1990-08-14 1990-09-26 Unilever Plc Moisture barrier and its preparation
EP0559827B1 (en) 1990-11-28 1997-08-27 R.P. Scherer Corporation High amylose starch substituted gelatin capsules
JPH04293460A (en) * 1991-03-20 1992-10-19 Mitsubishi Rayon Co Ltd Polysaccharide film and its production
JPH04372627A (en) * 1991-06-20 1992-12-25 Mitsubishi Rayon Co Ltd Polysaccharide film
US5224989A (en) 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
DE69223024T2 (en) 1991-12-16 1998-06-18 Nat Starch Chem Invest Edible foil
EP0633896B1 (en) 1992-03-31 1998-06-17 National Starch and Chemical Investment Holding Corporation Esterified starch composition
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
JPH05308910A (en) * 1992-05-01 1993-11-22 Osaka Kagaku Gokin Kk Water-resistant edible film good in heat sealability
KR100208979B1 (en) 1992-06-12 1999-07-15 야스이 쇼사꾸 Pharmaceutical preparation for intra-airway administration
NZ244796A (en) 1992-08-18 1995-05-26 Scherer Corp R P Capsule shell of soft gelatin contains a medicament and has a removable tab
JPH0665048A (en) * 1992-08-20 1994-03-08 Kibun Food Chemifa Co Ltd Filmy pack agent
JP3116602B2 (en) * 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 Hard capsule
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
GB9226392D0 (en) 1992-12-18 1993-02-10 Cpc International Inc Gelling agent
US5646206A (en) 1993-04-23 1997-07-08 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and poly(vinyl alchohol)
US5451673A (en) * 1993-04-23 1995-09-19 The United States Of America As Represented By The Secretary Of Agriculture Films fabricated from mixtures of pectin and starch
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
GB9313329D0 (en) * 1993-06-28 1993-08-11 Scherer Ltd R P Softgel capsule shell compositions
JPH07135913A (en) * 1993-11-19 1995-05-30 Sanei Gen F F I Inc Production of dessert jelly of multiple structure
JP2567566B2 (en) * 1994-03-01 1996-12-25 三栄源エフ・エフ・アイ株式会社 Drink jelly manufacturing method
US5528088A (en) * 1994-06-27 1996-06-18 Amphenol Corporation Current mode coupler with improved grounding
US6099876A (en) * 1994-10-11 2000-08-08 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Temperature-stable liquid cells
JP2959423B2 (en) * 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 Capsule coating composition
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
GB2298560B (en) 1994-12-23 1998-07-08 Cpc International Inc Low-fat cake donuts and process therefor
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US5656294A (en) 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
US5811388A (en) 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5614217A (en) * 1995-06-07 1997-03-25 R.P. Scherer Corporation Capsule shell formulation to produce brittle capsules
US5672699A (en) * 1995-09-06 1997-09-30 National Starch And Chemical Investment Holding Corporation Process for preparation of hydrophobic starch derivatives
US5549983A (en) * 1996-01-22 1996-08-27 Alliedsignal Inc. Coflow planar fuel cell stack construction for solid electrolytes
GB9606371D0 (en) * 1996-03-26 1996-06-05 Brown Malcolm D An encapsulation process
US5932639A (en) * 1996-05-06 1999-08-03 National Starch And Chemical Investment Holding Corporation Maltodextrin-based adhesives
US6214375B1 (en) * 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
US5743638A (en) * 1996-07-30 1998-04-28 Q-Jet, Dsi Dual control mixing jet cooker
US5726008A (en) * 1996-09-18 1998-03-10 Eastman Kodak Company Photographic elements with improved vehicles
DE19646392A1 (en) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
FR2757173A1 (en) 1996-12-17 1998-06-19 Warner Lambert Co POLYMERIC COMPOSITIONS OF NON-ANIMAL ORIGIN FOR FILM FORMATION
JPH10179045A (en) * 1996-12-25 1998-07-07 Osaka Kagaku Gokin Kk Sheet-like edible molding
US5813093A (en) * 1997-01-31 1998-09-29 Lucent Technologies Inc. Hinge assembly
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US5976586A (en) * 1997-03-10 1999-11-02 Lawrence Foods Glaze composition with vegetable gums
JP3238350B2 (en) * 1997-05-27 2001-12-10 三粧化研株式会社 Edible pearl-like capsule and method for producing the same
JP2931811B2 (en) * 1997-06-03 1999-08-09 ユニコロイド株式会社 Sustained release capsule
US6030641A (en) 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
FR2767070B1 (en) * 1997-08-08 1999-09-17 Laurence Paris AQUEOUS VISCOUS COMPOSITION, LIMPID OR NOT, FOR THE MANUFACTURE OF SOFT CAPSULES AND HARD CAPSULES, AND METHOD FOR MANUFACTURING FILMS FOR SUCH CAPSULES
JPH11130645A (en) * 1997-10-29 1999-05-18 Lion Corp Sheet for treatment of periodontosis
EP1032425A1 (en) * 1997-10-31 2000-09-06 Monsanto Company Gellan gum tablet coating
US6007614A (en) 1997-12-30 1999-12-28 National Starch And Chemical Investment Holding Corporation Starch esters as moisture vapor barrier coatings
GB9802201D0 (en) * 1998-02-03 1998-04-01 Cerestar Holding Bv Free-flowable directly compressible starch as binder,disintegrant and filler for compresion tablets and hard gelatine capsules
US5962053A (en) * 1998-02-17 1999-10-05 Viskase Corporation Edible film and method
US6146570A (en) * 1998-03-20 2000-11-14 Rhodia Inc. Process for producing extruded hydrocolloid granules
US6187293B1 (en) 1998-04-27 2001-02-13 Fmc Corporation Process for making toothpaste using low levels of carrageenan
JP3182393B2 (en) * 1998-05-13 2001-07-03 三菱レイヨン株式会社 Carrageenan for low temperature gelation
KR20000011247A (en) * 1998-07-23 2000-02-25 김윤 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides
US6063915A (en) 1998-07-30 2000-05-16 Hercules Incorporated Carrageenan compositions and methods for their production
US6214376B1 (en) * 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US6268191B1 (en) * 1998-09-21 2001-07-31 Robert K. Prud'homme Enzyme immobilization by imbibing an enzyme solution into dehydrated hydrocolloid gel beads
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
AU762692C (en) * 1998-09-30 2007-01-11 Warner-Lambert Company Modified starch film compositions
US6635275B1 (en) * 1999-01-29 2003-10-21 Warner-Lambert Company Modified starch film compositions
JP2000125801A (en) 1998-10-22 2000-05-09 Japan Tobacco Inc Granule of fushis
GB9824658D0 (en) * 1998-11-11 1999-01-06 Brown Malcolm D A capsule based drug delivery system
US6352719B1 (en) 1998-11-11 2002-03-05 Bioprogress Technology International, Inc. Capsule based drug delivery system
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6210709B1 (en) * 1999-03-24 2001-04-03 Elementis Specialties, Inc. Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
JP2002543817A (en) 1999-05-12 2002-12-24 シーピー・ケルコ・エイピーエス High solids content food formulations, methods for their preparation and use of carrageenans for gelling food formulations
WO2001002478A1 (en) * 1999-07-06 2001-01-11 The Procter & Gamble Company Pre-formed, self-adhesive sheet devices suitable for topical application
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
ATE291420T1 (en) * 1999-11-19 2005-04-15 Swiss Caps Rechte & Lizenzen METHOD FOR PRODUCING A MOLDED BODY CONTAINING STARCH, HOMOGENIZED MASS CONTAINING STARCH AND DEVICE FOR PRODUCING A SOFT CAPSULE
WO2001041776A2 (en) * 1999-12-09 2001-06-14 Waikatolink Limited Use of honey in medical dressings
US6387354B1 (en) 2000-03-06 2002-05-14 Shemberg Marketing Corporation Semi-refined carrageenan dentifrice binder
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
JP3481580B2 (en) * 2000-04-11 2003-12-22 三栄源エフ・エフ・アイ株式会社 Elastic food composition and method for producing the same
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
US6375981B1 (en) * 2000-06-01 2002-04-23 A. E. Staley Manufacturing Co. Modified starch as a replacement for gelatin in soft gel films and capsules
US6528088B1 (en) 2000-06-01 2003-03-04 A. E. Staley Manufacturing Co. Highly flexible starch-based films
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
ATE349204T1 (en) 2000-11-09 2007-01-15 Celanese Ventures Gmbh SOFT CAPSULES COMPRISING A STARCH MIXTURE WITH A REDUCED BRANCHING DEGREE
EP1339395A2 (en) * 2000-11-28 2003-09-03 Fmc Corporation Edible pga (propylene glycol alginate) coating composition
US6479649B1 (en) 2000-12-13 2002-11-12 Fmc Corporation Production of carrageenan and carrageenan products
JP2002186427A (en) * 2000-12-19 2002-07-02 Sanei Gen Ffi Inc Frozen dessert
US6814978B2 (en) * 2000-12-29 2004-11-09 Mcneil-Ppc, Inc. Process for preparing a soft tablet
JP4336875B2 (en) * 2001-03-19 2009-09-30 大正製薬株式会社 Gel composition
US7293910B2 (en) * 2001-05-24 2007-11-13 Masco Corporation Surge suppressor for a mixer head assembly
JPWO2003004003A1 (en) * 2001-07-05 2004-10-21 湧永製薬株式会社 Soft capsule
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
WO2003030881A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Glucan based film delivery systems
DE10214327A1 (en) * 2001-10-23 2003-05-22 Innogel Ag Zug Polysaccharide-based network and process for its manufacture
ATE397918T1 (en) 2001-10-23 2008-07-15 Innogel Ag PRODUCTION OF MOLDED BODIES BASED ON STARCH CONE GEL
JP2003125714A (en) * 2001-10-29 2003-05-07 Ina Food Ind Co Ltd Capsule base material and capsule made from the base material, and method for producing the capsule base material
US6884060B2 (en) * 2001-11-02 2005-04-26 R.P. Scherer Technologies, Inc. Apparatus for manufacturing encapsulated products
US6745546B2 (en) 2001-11-02 2004-06-08 R.P. Scherer Technologies, Inc. Encapsulation machine with valved injection wedge
CA2463250A1 (en) * 2001-11-16 2003-05-30 Givaudan Sa Edible film
CN100335133C (en) * 2001-11-22 2007-09-05 森下仁丹株式会社 Non-gelatinous capsule film compositions and capsules using the same
JP2003192615A (en) * 2001-12-26 2003-07-09 Nissei Kosan Kk Method for producing capsule
FR2829142B1 (en) 2001-12-27 2004-02-13 Ulice FILMOGENEOUS COMPOSITION OF HETEROXYLANE FOR THE MANUFACTURE OF CAPSULES THUS OBTAINED
JP2003199809A (en) * 2002-01-09 2003-07-15 Toyo Capsule Kk Soft capsule shell
US7887838B2 (en) 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
US6949256B2 (en) * 2002-01-18 2005-09-27 Banner Pharmacaps, Inc. Non-gelatin capsule shell formulation
NO20021592D0 (en) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysaccharide Capsules and Method of Preparation thereof
JP2003299714A (en) 2002-04-10 2003-10-21 Fuji Capsule Kk Film composition of soft capsule
JP4000279B2 (en) * 2002-05-29 2007-10-31 富士フイルム株式会社 Recording tape cartridge
US20040013723A1 (en) * 2002-07-16 2004-01-22 PARIKH Rita M. Oral care capsules
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
JP2004167084A (en) 2002-11-21 2004-06-17 Ina Food Ind Co Ltd Soft capsule coating film, its raw material, and soft capsule
US6987182B2 (en) 2003-03-26 2006-01-17 North Carolina State University Process for producing cold-gelling hydrocolloids
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
KR101128201B1 (en) * 2003-04-14 2012-03-23 에프엠씨 코포레이션 Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
US20050008677A1 (en) * 2003-04-14 2005-01-13 Fmc Corporation Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
US7816341B2 (en) * 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20050048185A1 (en) * 2003-04-14 2005-03-03 Fmc Corporation Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films
US20050019295A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
US20050019294A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018365A2 (en) * 1998-09-25 2000-04-06 Warner-Lambert Company Fast dissolving orally consumable films
WO2002043657A2 (en) * 2000-11-30 2002-06-06 Wm. Wrigley Jr. Company Improved pullulan free edible film compositions and methods of making the same

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073346A1 (en) * 2005-12-23 2007-06-28 Kjell Stenberg Water-soluble films comprising low-viscosity alginates
JP2009521433A (en) * 2005-12-23 2009-06-04 ステンバーグ,カージェル Water-soluble thin film containing low viscosity alginate
RU2445977C2 (en) * 2005-12-23 2012-03-27 Упсалагрупен Медикал Аб Water-soluble films containing low-viscosity alginates
US8759282B2 (en) 2005-12-23 2014-06-24 Uppsalagruppen Medical Ab Water-soluble films comprising low-viscosity alginates
KR101484530B1 (en) 2005-12-23 2015-01-20 웁살라그루펜 메디칼 에이비 Water-soluble films comprising low-viscosity alginates
NO343482B1 (en) * 2005-12-23 2019-03-25 Uppsalagruppen Medical Ab Water-soluble films comprising low viscosity alginates
JP2008072915A (en) * 2006-09-19 2008-04-03 Dhc Co Film-like food
US10814005B2 (en) * 2013-04-02 2020-10-27 Paxtree Ltd. Composition as auxiliary means for oral medication
US11419940B2 (en) 2013-04-02 2022-08-23 Paxtree Ltd. Composition as auxiliary means for oral medication

Also Published As

Publication number Publication date
CA2522295A1 (en) 2004-10-28
BRPI0409342A (en) 2006-04-25
JP2007526209A (en) 2007-09-13
EP1622588A2 (en) 2006-02-08
WO2004091527A3 (en) 2005-08-18
EP1622594A2 (en) 2006-02-08
EP1628620A2 (en) 2006-03-01
JP2007528357A (en) 2007-10-11
EP1622594A4 (en) 2010-07-14
JP2007525551A (en) 2007-09-06
WO2004091533A3 (en) 2006-05-18
WO2004091527B1 (en) 2005-10-06
CA2522293A1 (en) 2004-10-28
EP1628620A4 (en) 2010-01-06
US20080089934A1 (en) 2008-04-17
WO2004091533A2 (en) 2004-10-28
JP2006524743A (en) 2006-11-02
WO2004091528A3 (en) 2005-01-27
JP2007526210A (en) 2007-09-13
EP1617825A2 (en) 2006-01-25
MXPA05011026A (en) 2005-12-12
WO2004091529B1 (en) 2005-05-19
JP2007525451A (en) 2007-09-06
KR20060011954A (en) 2006-02-06
WO2004091532A3 (en) 2006-05-18
MXPA05011028A (en) 2005-12-12
CA2522297A1 (en) 2004-10-28
JP4558721B2 (en) 2010-10-06
WO2004091538A3 (en) 2005-04-07
EP1628643B1 (en) 2013-02-27
BRPI0409336A (en) 2006-04-25
WO2004091539A2 (en) 2004-10-28
EP1617815A2 (en) 2006-01-25
KR20060003350A (en) 2006-01-10
KR20060011953A (en) 2006-02-06
US7807194B2 (en) 2010-10-05
CA2522296A1 (en) 2004-10-28
WO2004091527A2 (en) 2004-10-28
BRPI0409334A (en) 2006-04-25
MXPA05011027A (en) 2005-12-12
JP4602326B2 (en) 2010-12-22
BRPI0409357A (en) 2006-04-25
WO2004091537A2 (en) 2004-10-28
WO2004091529A3 (en) 2005-02-24
US20050084516A1 (en) 2005-04-21
WO2004091537A3 (en) 2005-05-06
JP2007526211A (en) 2007-09-13
BRPI0409329A (en) 2006-04-25
WO2004091530A3 (en) 2005-03-03
WO2004091529A2 (en) 2004-10-28
WO2004091537B1 (en) 2005-07-14
KR101128201B1 (en) 2012-03-23
EP1628643A2 (en) 2006-03-01
BRPI0409343A (en) 2006-04-25
MXPA05011029A (en) 2005-12-12
BRPI0409357B1 (en) 2018-02-06
JP2006526057A (en) 2006-11-16
EP1620114A2 (en) 2006-02-01
KR20060011955A (en) 2006-02-06
WO2004091528B1 (en) 2005-03-24
WO2004091530B1 (en) 2005-04-21
WO2004091539A3 (en) 2005-05-06
CA2522298A1 (en) 2004-10-28
IL171291A (en) 2010-12-30
US20050019374A1 (en) 2005-01-27
EP1628643A4 (en) 2010-01-06
BRPI0409357B8 (en) 2021-05-25
WO2004091532A2 (en) 2004-10-28
WO2004091538B1 (en) 2005-05-26
EP1628643B9 (en) 2013-06-12
CA2522295C (en) 2012-02-07
WO2004091538A2 (en) 2004-10-28
EP1620059A2 (en) 2006-02-01
PL1628643T3 (en) 2013-09-30
WO2004091530A2 (en) 2004-10-28
BRPI0409345A (en) 2006-04-25

Similar Documents

Publication Publication Date Title
WO2004091528A2 (en) Delivery systems of homogeneous thermoreversible alginate films
US7816341B2 (en) Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20090208569A1 (en) Homogeneous, Thermoreversible Alginate Films and Soft Capsules Made Therefrom
US20050013847A1 (en) Delivery systems of homogeneous, thermoreversible alginate films
ZA200508251B (en) Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
US20050008677A1 (en) Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
US20050019295A1 (en) Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
US20050048185A1 (en) Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films
CN1791385A (en) Homogeneous, thermoreversible alginate films transportation system
RU2341250C2 (en) Homogeneous thermal reversible gel film containing cappa-2-carraginan, and soft capsules produced thereof
RU2341290C2 (en) Homogeneous, thermally reversible gel containing carragenan of underviscosity, and products made thereof
ZA200508253B (en) Homogeneous, thermoreversible alginate films and soft capsules made therefrom

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
B Later publication of amended claims

Effective date: 20050203

WWE Wipo information: entry into national phase

Ref document number: 2006510060

Country of ref document: JP

Ref document number: 4643/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2004759551

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 20048140069

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2004759551

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0409336

Country of ref document: BR